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summary of the recent occurrence of micropollutants in the aquatic environment including sewage,
surface water, groundwater and drinking water. The discharge of treated effluent from WWTPs is a major
pathway for the introduction of micropollutants to surface water. WWTPs act as primary barriers against
the spread of micropollutants. WWTP removal efficiency of the selected micropollutants in 14 countries/
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osmosis, and membrane bioreactors can achieve higher and more consistent micropollutant removal.
However, regardless of what technology is employed, the removal of micropollutants depends on physicochemical properties of micropollutants and treatment conditions. The evaluation of micropollutant
removal from municipal wastewater should cover a series of aspects from sources to end uses. After the
release of micropollutants, a better understanding and modeling of their fate in surface water is essential
for effectively predicting their impacts on the receiving environment.
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Abstract
Micropollutants are emerging as a new challenge to the scientific community. This review
provides a summary of the recent occurrence of micropollutants in the aquatic
environment including sewage, surface water, groundwater and drinking water. The
discharge of treated effluent from WWTPs has been a major pathway for the introduction of
micropollutants to surface water. WWTPs act as primary barriers against the spread of
micropollutants. WWTP removal efficiency of the selected micropollutants in 14
countries/regions depicts compound-specific variation in removal, ranging from 12.5 to 100%.
Biodegradation is a significant removal pathway for some pharmaceuticals and steroid
hormones but of minor importance for antibiotics and pesticides. Sorption serves as the main
removal mechanism for industrial chemicals and musks. Advanced treatment processes, such
as activated carbon adsorption, advanced oxidation processes, reverse osmosis, and
membrane bioreactors can achieve higher and more consistent micropollutantds removal.
However, no matter what technology is employed, the removal of micropollutants depends on
phsyico-chemical properties of micropollutants and the treatment conditions. Additionally, a
better monitoring of micropollutants in surface waters is essential for effectively predicting
micropollutants’ impacts on the receiving environment.
Keywords: Micropollutants, Occurrence, Fate, Removal, WWTP, Advanced treatment.
Abbreviations and symbols: AOP: advanced oxidation process; ASFBBR: aerated submerged fixed
bed bioreactor; BAC: biological activated carbon; CAS: conventional activate sludge; DBP: di-butyl
phthalate; DEET: N,N-Diethyl-meta-toluamide; DEHP: di-(2-ethylhexyl) phthalate; DMP: di-methyl
phthalate; DOM: dissolved organic matters; EDCs: endocrine disrupting compounds; GAC: granule
activated carbon; HRT: hydraulic retention time; Kd: solid-water distribution coefficient; kH: Henry’s
law constant; Kow: octanol-water partition coefficient; MBR: membrane bioreactor; MBBR: moving
bed biofilm reactor; MF: microfiltration; NF: nanofiltration; NSAID: nonsteroidal anti-inflammatory
drugs; PAC: powdered activated carbon. PCP: personal care product; pKa: acid dissociation constant;
PNEC: predicted no effect concentrations; PPCP: pharmaceutical and personal care product; RO:
reverse osmosis; SBBGR: sequencing batch biofilter granular reactor; SRT: sludge retention time;
TCEP: tris(2-chloroethyl)phosphate; TCPP: tris(1-chloro-2-propyl) phosphate; UF: ultrafiltration;
WWTP: wastewater treatment plant.
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1. Introduction
Over the last few decades, the occurrence of micropollutants in the aquatic environment
has become a worldwide issue of increasing environmental concern. Micropollutants, also
termed as emerging contaminants, consist of a vast and expanding array of anthropogenic as
well as natural substances. These include pharmaceuticals, personal care products, steroid
hormones, industrial chemicals, pesticides and many other emerging compounds.
Micropollutants are commonly present in waters at trace concentrations, ranging from a few
ng/L to several µg/L. The ‘low concentration’ and diversity of micropollutants not only
perplexes the associated detection and analysis procedures but also creates challenges for
water and wastewater treatment processes.
Current wastewater treatment plants (WWTPs) are not specifically designed to eliminate
micropollutants. Thus, many of these micropollutants are able to pass through wastewater
treatment processes by virtue of their persistency or/and the continuous introduction. In
addition, precautions and monitoring actions for micropollutants have not been well
established in most WWTPs (Bolong et al., 2009). Consequently, many of these compounds
may end up in the aquatic environment, becoming threats to wildlife and spelling trouble for
drinking water industry. The occurrence of micropollutants in the aquatic environment have
been frequently associated with a number of negative effects, including short-term and longterm toxicity, endocrine disrupting effects and antibiotic resistance of microorganisms (Fent
et al., 2006; Pruden et al., 2006). To date, discharge guidelines and standards do not exist for
most micropollutants. To set regulatory limits for micropollutants, further research on
2

biological responses to these compunds (both short-term and long-term effects) is of
particular importance. Futhermore, the scientific and regulatory communities should give
insight into not only the impact of individual micropollutant, but also their synergistic and
antagonistic effects (Bhandari, 2009).
Several review papers have been published with regard to the occurrence of
micropollutants in different water bodies such as wastewater (Deblonde et al., 2011) and
groundwater (Lapworth et al., 2012), as well as treatment methods for micropollutant
removal (Bolong et al., 2009). In addition, Verlicchi et al. (2012) reviewed the
pharmaceutical removal efficiency in conventional activated sludge systems and in MBR fed
by municipal wastewater, while Ze-hua Liu et al. (2009) focused on the physical, chemical
and biological removal of endocrine disrupting compounds (EDCs). However, no attempt has
been made to provide a comprehensive summary of the occurrence of miscellaneous
micropollutants in aquatic systems as well as the removal of micropollutants in conventional
and advanced treatment processes. In this review, we systematically summarized the recent
occurrence of various micropollutants in the aquatic environment and delineated the
behaviour and removal of micropollutants during conventional as well as advanced
wastewater treatment processes.

2. Occurrence of micropollutants in the aquatic environment
Sources of micropollutants in the environment are diverse and many of these originate
from mass-produced materials and commodities. Table 1 summarizes the source categories of
some major micropollutants in aquatic ecosystem. Figure 1 illustrates the possible routes for
the introduction of micropollutants into the environment.
Table 1
Fig. 1.
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The recent occurrence (2008 to date) of the micropollutants in the aquatic environment
has been reviewed in terms of their aqueous concentrations in different types of waters,
including wastewater, surface waters, groundwater and drinking water. Of all aqueous media,
WWTP influent and effluent are comprehensively reviewed. The collected data consist of the
studies performed in a number of countries/regions, including Austria, China, EU-wide,
France, Germany, Greece, Italy, Korea, Spain, Sweden, Switzerland, Western Balkan Region,
UK and US. In general, micropollutants can be divided into six categories namely
pharmaceuticals, personal care products (PPCPs), steroid hormones, surfactants, industrial
chemicals and pesticides.

2.1 Occurrence of micropollutants in WWTPs
Occurrence data of micropollutants in WWTP influent and effluent from recent studies
(2008present) are summarized in Table 2. As can be noted from the table, the reported
concentrations of micropollutants in WWTP influent and effluent reveal significant spatial
and temporal variations, which are essentially due to a number of factors, including the rate
of production, specific sales and practices, metabolism (excretion rate), water consumption
per person and per day, the size of WWTPs, environmental persistence and elimination
efficacy of wastewater treatment processes (Petrovic et al., 2009; Jelic et al, 2012).
Table 2
The local production and usage/consumption of products containing micropollutants
determine the amount of micropoullutants reaching WWTPs. Studies suggested that PPCP
concentrations in wastewater correlated well with their production amounts and
usage/consumption patterns. Choi et al. (2008a) reported that the occurrence concentrations
of acetaminophen, carbamazepine, cimetidine, diltiazem, sulfamethoxazole and trimethoprim
followed the same order (from highest to lowest) of their annual production amount in Korea.
4

High concentrations (>10 µg/L) of paracetamol, tramadol, codeine, gabapentin and atenolol
were detected at highest levels in raw wastewater in Wales, UK and this could be explained
by the high quantities of these pharmaceuticals dispensed (Kasprzyk-Hordern et al., 2009).
As orally ingested products containing potential contaminants (e.g. pharmaceuticals) are
metabolized in human body and are subsequently excreted via urine and feces, excretion rate
plays a role in determining the introduction of pharmaceuticals into raw wastewater. Table 3
presents the excretion rates for some commonly encountered pharmaceuticals. It can be noted
that pharmaceutical compounds with low excretion rates (e.g., ibuprofen, carbamazepine,
sulfamethoxazole, diclofenac and primidione) are not necessarily present at low levels in the
raw wastewater. This is possibly because the low excretion rates are offset by the massive use
of these compounds. In addition, local common diseases can induce a higher consumption of
specific pharmaceuticals in certain periods. Research showed climatic conditions could cause
fluctuating micropollutant input (Kolpin et al., 2004). For instance, the use of pesticides can
be seasonal due to the prevalence of pests in different climatic conditions. Another important
factor is rainfall, as it affects the flow pattern of wastewater influent when a combined sewer
system is employed. Kasprzyk-Hordern et al. (2009) found that the concentrations of most
PPCPs in the raw wastewater were doubled when the flow was halved during dry weather
conditions, suggesting that rainwater could dilute the concentration of the compounds within
the sewage. Other weather conditions, such as temperature and level of sunlight also can
affect the discharge of micropollutants from WWTPs.
Table 3
Occurrence levels of some of the most studied compounds in WWTP influent and
effluent are presented in Fig. 2. As can be seen in Fig. 2, most micropollutants occurred in
WWTP influent in the concentration range from 0.1 to 10 µg/L, while some pharmaceutical
compounds (acetaminophen, caffeine, ibuprofen, naproxen and salicylic acid), a biocide
5

(triclosan), one surfactant (Nonylphenol) and one industrial chemicals (DEHP) exhibit
relatively higher occurrence concentration. Generally, the compounds with the highest
concentrations (mean values > 10 µg/L) in WWTP influent were ibuprofen, atenolol, caffeine
and nonylphenol. For instance, ibuprofen was the most abundant compound detected in the
influent of four WWTPs in Spain, with the concentration levels ranging from 3.73 to 603
µg/L (Santos et al., 2009). The particularly high levels could be explained by the high
consumption and easy accessibility (over the counter drugs) of the compound (CamachoMuñoz et al., 2010). Caffeine was detected at the highest levels approaching 50 µg/L on
average in raw sewage in three WWTPs in China (Zhou et al., 2010). The abundant presence
of caffeine is likely associated with the high consumption of coffee, tea and soft drinks as
well as the disposal of these items. Steroid hormones and pesticides generally exhibit lower
detected concentrations (mostly less than 1 µg/L) as compared with compounds from other
groups. The concentrations of most micropollutants in effluent ranged from 0.001 to 1 µg/L,
which were one to two orders of magnitude lower than those in influent. Some abundant
compounds in influent were discharged at relatively high concentrations. For instance,
atenolol, caffeine, DEHP, ibuprofen, naproxen, nonylphenol and triclosan were detected in
the concentrations higher than 1 µg/L in treated effluent. In contrast, steroid hormones were
found in wastewater at much lower levels (<100 ng/L). However, their occurrence even at
low concentrations is a concern because of their high estrogenic effect.
Fig. 2.

2.2 Occurrence of micropollutants in surface water
The release of WWTP effluent into surface water has been considered as a main cause of
the presence of micropollutants in surface water in comparison to other sources (KasprzykHordern et al., 2009). Following treatment processes in WWTPs, micropollutants are
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subjected to varying degrees of natural attenuation (e.g., dilution in surface water, sorption
onto suspended solids and sediments, direct and indirect photolysis and aerobic
biodegradation) (Pal et al., 2010). Due to river water dilution, pharmaceutical compounds
may occur at levels at least one order of magnitude lower than effluent levels (Gros et al.,
2007). Gómez et al. (2012) found that the natural attenuation of PCPs is more likely to result
from river water dilution, or sorption to solids, than from degradation. Furthermore, river
water dilution can be affected by rainfall. Consistent increase in micropollutant occurrence
levels during dry weather conditions and marked reduction during wet weather conditions
have been reported. Wang et al. (2011) indicated that pharmaceuticals in summer water
samples showed lower occurrence levels than those in winter. This could be due to 1)
promoted biodegradation of pharmaceuticals in warmer temperature, and 2) elevated dilution
during wetter summer. However, rainfall did not always reduce the concentration levels of
micropollutants released. In some cases, rainfall was identified as a contributor to the
emission of micropollutants to surface water. Some studies revealed that the chemicals (e.g.,
bisphenol A and biocides) used in building material (e.g. pavement materials, facades and
roof paintings) were able to leach during precipitation and accumulate to remarkable levels in
roof runoff and subsequently ended up in surface water (Sakamoto et al., 2007; Jungnickel et
al., 2008; Schoknecht et al., 2009; Singer et al., 2010). In addition, rainfall events could
intensify combined sewer overflows, resulting in a higher level of contaminant discharge.
According to Table 4 showing common micropollutants in surface water from different
countries, nonsteroidal anti-inflammatory drugs (NSAIDs), carbamazepine, sulfamethoxazole
and triclosan were the most frequently reported compounds in surface water. The high
concentrations of micropollutants were found in Costa Rica, which mainly resulted from the
discharge of hospital effluents and other highly contaminated waters (Spongberg et al., 2011).
Notably, ibuprofen, ketoprofen, gemfibrozil and caffeine were detected at alarmingly high
7

levels, with maximum concentrations of 36.8, 9.8, 17.0 and 1121.4 µg/L, respectively.
Caffeine was also detected at relatively high concentrations in US (224.8 ng/L) and Taiwan
(1813 ng/L). Unlike Costa Rica, the reported caffeine concentrations in US and Taiwan were
far below the predicted no effect concentrations (PNECs). Hence, the pollution of emerging
contaminants in the natural water bodies of the densely populated regions may be more
severe because of the massive usage of these chemicals by the large population. For example,
the concentrations of nonylphenol, bisphenol A and triclosan in the surface water of
Guangzhou (one of the largest cities in China) were rather high, and nonylphenol was also
found at relatively high concentrations in a Greek river, with a maximum of 2704 ng/L. It is
noteworthy that the maximum nonylphenol concentrations in China and Greece were well
above the reported PNEC for nonylphenol. Besides, population aging has also been linked to
the high occurrence levels of pharmaceuticals (Al-Rifai et al., 2007).
Table 4

2.3 Occurrence of micropollutants in groundwater
In comparison to surface water, ground water was found to be less contaminated with
micropollutants (Loos et al., 2010; Vulliet and Cren-Olivé, 2011). Hence, the presence of
micropollutants in groundwater has been put far less emphasis on. Better characterization of
micropollutants in groundwater has been only done regionally (mainly in some parts of
Europe and North America). Micropollutant contamination of groundwater mainly results
from landfill leachate, groundwater-surface water interaction, infiltration of contaminated
water from agricultural land or seepage of septic tanks and sewer systems. Concentrations of
micropollutants in landfill leachate and septic tank leakage generally range from 10 to 104
ng/L and 10 to 103 ng/L, respectively (Lapworth et al., 2012). Micropollutants can also be
introduced in groundwater via bank filtration or artificial recharge using reclaimed water
8

(Stepien et al., 2013). Normally, the processes governing subsurface flow and transport (such
as dilution, adsorption to aquifer material, degradation and travel time) can decrease
micropollutants’ concentrations from the sources (e.g., landfill leachate and septic tank
leakage) to groundwater (Teijon et al., 2010). The physicochemical properties of
micropollutants are therefore important for the transfer of the compounds to groundwater. For
example, Octanol-Water partition coefficient Kow indicates contaminant mobility in the
subsurface, where the compounds (e.g, trimethoprim and TCEP) with Kow < 1.5 tend to stay
in the dissolved phase (more mobility) and are more likely to occur in groundwater
(Dougherty et al., 2010; Karnjanapiboonwong et al., 2011). In a study conducted in US, Fram
and Belitz (2011) found good correlation of pharmaceutical levels in groundwater and
presence of modern water (water recharged since 1953), occurrence of other synthetic
contaminants (urban-use herbicides and insecticides and volatile organic compounds) and
land application.
For selected countries (Table 5), most of the compounds were detected at less than 100
ng/L in groundwater. NASIDs, carbamazepine, sulfamethoxazole, caffeine and triclosan were
of particular research interest. These compounds were also the most commonly detected ones
in surface water and wastewater, evidencing a correlation of the presence of micropollutants
in different aquatic systems. By comparing the occurrence concentrations of micropollutants
with PNEC, most of the compounds were at levels without potential environmental
significance. However, considerably high concentrations (2 or 3 orders of magnitude higher
than PNEC) of steroid hormones were found in groundwater at a US land application site
(Karnjanapiboonwong et al., 2011). The problem probably resulted from the application of
wastewater effluent to a portion of the soil. Although the authors did not point out the adverse
effects of the high-level steroid hormones, their occurrence would be of potential concern if
the groundwater was utilized for direct or indirect potable water reuse.
9

Table 5

2.4 Occurrence of micropollutants in drinking water
A small mass of is available with regard to the occurrence of micropollutants in drinking
water (Vulliet et al., 2011). Some recent studies showed that most micropollutants in finished
waters from drinking water treatment were below limit of quantitation or limit of detection
(Benotti et al., 2008, Huerta-Fontela et al., 2011, Kleywegt et al. 2011, Wang et al., 2011).
Therefore, only the data of the most abundant compounds have been presented in Figure 3.
To date, there has been a lack of guidelines for risk assessment for the presence of most
micropollutants in drinking water. PNEC values were plotted to superficially describe the
potential of negative effects (Figure 3). The occurrence levels of micropollutants in drinking
water were dependent on water sources and seasons, with winter water samples showing
higher concentrations in comparing to summer water samples. Furthermore, drinking water
treatment plays a significant role in eliminating micropollutants from drinking water and has
therefore been comprehensively examined (Stackelberg et al., 2004; Westerhoff et al., 2005).
As can be seen in Figure 3, the maximum occurrence concentrations of most
micropollutants were reported to be below 100 ng/L, with the exception of carbamazepine
and caffeine. Notably, carbamazepine was observed at a concentration exceeding 600 ng/L (a
concentration more than 10 times higher than those of most other compounds) in the study
conducted by Kleywegt et al. (2011). The high levels of carbamazepine could be explained
by its high persistency. Even so, the occurrence level of carbamazepine was far below the
PNEC (25000 ng/L). It is also noteworthy that nonylphenol showed a maximum
concentration (100 ng/L) most close to PNEC (330 ng/L, less than 1 order of magnitude).
Other compounds were all at safe levels, since the PNEC values were 2 to 5 orders of
magnitude higher than the their maximum concentrations. Overall, based on the studies
10

reviewed here, these countries were all able to rule out the adverse impacts of selected
micropollutants on drinking water. Nevertheless, since other compounds as well as
transformation by-products, which can also pose adverse effects, were not monitored in these
studies, the safety of the produced drinking water still needs to be under scrutiny.
Fig. 3.

3. The removal and fate of micropollutants in WWTPs
Municipal WWTPs are designed to control a wide range of substances, such as
particulates, carbonaceous substances, nutrients and pathogens. While these substances can
be efficiently and consistently removed, the removal of micropollutants is basically under no
control. Hence, the evaluation of the fate and removal of micropollutants during wastewater
treatment is imperative for the optimization of treatment processes, in order to prevent the
release of these potentially harmful micropollutants.

3.1 The fate of micropollutants in WWTPs
Wastewater treatment plants generally employ a primary, a secondary and an optional
tertiary treatment process. Tertiary treatment processes are commonly used to produce higher
quality of discharged water for certain purposes (e.g. water reuse), which are always
associated with high treatment cost. Thus, the requirement for tertiary treatment processes is
generally based on public and environmental health objectives.
Primary treatment processes aims to remove suspended solids that enter WWTPs.
Micropollutants are removed mainly by sorption on primary sludge, as distribution of a
compound into organic (lipophilic) layer is a predominant way of sorption (Ternes et al.,
2004). Fragrances (galaxolide and tonalide) were found to be well removed (40%) during
primary treatment (aerated grit chamber followed by circular sedimentation tank) due to their
11

high partition coefficients between the solid and liquid phase (Carballa et al., 2004). Primary
treatment (sedimentation tank) was also able to remove some EDCs moderately with removal
efficiency ranging from 13% (nonylphenol monoethoxylate) to 43% (Bisphenol A)
(Stasinakis et al., 2013). However, primary treatment using aerated grit chamber could cause
significant increase of phenolic compounds, such as bisphenol A and nonylphenol, because
the compounds originally attached to the grits could be peeled off due to air agitation in grit
chamber (Nie et al., 2012). For pharmaceuticals and hormones, removal efficiency in primary
treatment ranged up to only 28% (diclofenac and estriol), which suggested that adsorption of
investigated compounds to sludge particles was rather limited (Behera et al., 2011). No
considerable reduction was also reported for ibuprofen, naproxen, sulfamethoxazol and
estrone (Carballa et al., 2004).
In secondary treatment, micropollutants are subjected to a range of processes, including
dispersion, dilution, partition, biodegradation and abiotic transformation. The total removal
during secondary treatment generally refers to the losses of a parent compound contributed
by different mechanisms of chemical and physical transformation, biodegradation and
sorption to solids (Jelic et al., 2011). Biodegradation/biotransformation and sorption are the
two major removal mechanisms during biological treatment, while volatilisation occurs to a
minor degree (Verlicchi et al., 2012).
During secondary treatment, micropollutants are biologically degraded to various
degrees, resulting in mineralisation or incomplete degradation (production of by-products).
Biodegradation of micropollutants can occur via different mechanisms: 1) single substrate
growth of a small subset of specialist oligotrophic organisms, which is less common in
WWTPs and more likely to occur in receiving water or sediment (Daughton and Ternes,
1999); 2) co-metabolism, in which micropollutants are decomposited by enzymes generated
for other primary substation degradation (e.g. ammonia monooxygenase (AMO)) and are not
12

used as carbon and energy source for microbial growth; and 3) mixed substrate growth, in
which micropollutants are used as carbon and energy souce and become mineralized (Vader
et al., 2000). For pharmaceuticals, even if the compounds fall into the same therapeutical
group, their biodegradability can show great variability. For example, Salgado et al. 2012
reported, among NSAIDs, diclofenac exhibited low (<25%) biodegradation, whereas
ibuprofen and ketoprofen were biodegradated to a much higher extent (>75%). Anticbiotics
are generally not readily biodegradable (Verlicchi et al., 2012). Regarding polycyclic musk,
Clara et al., (2011) indicated biological degradation serves as a minor removal pathway. 15%
and 30% of galaxolide and tonalide were found to be eliminated via biological transformation
(Salgado et al., 2012). In contrast, Suarez et al., (2010) reproted much higher biodegradation
of tonalide and galaxolide (>75%). As for steroid hormones, significant biodegradation
(>75%) was observed for estrone and estradiol (Suarez et al., 2010). Bisphenol A and
triclosan were also found to be susceptible to biodegradation (up to 85% and 81%
respectively), while nonylphenol was biologically transformed to a lesser degree (up to 56%)
in two WWTPs using activated sludge (Samaras et al., 2013). In the case of pesticide,
Stasinakis et al. (2009) found almost 60% of diuron was biodegraded during a activated
sludge process.
Sorption of micropollutants mainly occurs by (1) absorption, in which hydrophobic
interactions occur between the aliphatic and aromatic groups of a compound and the
lipophilic cell membrane of microorganisms as well as the fat fractions of sludge, and (2)
adsorption, involving the electrostatic interactions of the positively charged groups with the
negatively charged surfaces of the microorganisms and sludge (e.g. amino groups) (Ternes et
al., 2004). Verlicchi et al. (2012) found that sorption onto solids is insignificant (<5% in most
cases) for most pharmaceuticals. In a study, mefenamic acid showed about 30% sorption
(Jelic et al., 2011). In contrast, it was the major removal mechanism for some compounds,
13

such as diclofenac, galaxolide, tonalide (Clara et al., 2011; Salgado et al., 2012).
Nonylphenol (35% to 51%) and triclosan (11% to 41%) were detected to be moderately
removed via sorption to solids, while some acidic compounds (e.g., ibuprofen) could not be
sorbed because of the charge repulsion between solids and compounds (Samaras et al., 2013).
The compounds that tend to be sorbed onto solids are expected to be better eliminated by
activated sludge treatment than other low-cost secondary treatments (trickling fiter beds,
anaerobic lagoon and constructed wet lands) (Camacho-Muñoz et al., 2012). This can be due
to the promoted biodegradation under forced aeration during the conventional treatments,
together with the enhanced sorption by large amounts of sludge generated in conventional
treatment systems.
In WWTPs, there are circumstances where the effluent concentrations of some
micropollutants exceed their influent concentrations. This can be explained by the presence
of some substances, e.g. human metabolites and/or transformation products in the influent,
which can subsequently be transformed back to parent compounds during biological
treatment (e.g. diclofenac, carbamazepine, erythromycin, and sulfamethoxazole) (Göbel et al.,
2007; Kasprzyk-Hordern et al., 2009). In addition, some pharmaceuticals excreted with feces
are probably partly enclosed in feces particles and released during biological treatment. The
negative removal has also been ascribed to the daily concentration fluctuations during the
sampling period, the analytical uncertainty, or desorption of molecules from sludge and
suspended particulate matter (Clara et al., 2004; Köck-Schulmeyer et al., 2013).
3.1 Overall removals of micropollutants in conventional WWTPs
The term “overall removal” generally refers to all the losses of micropollutant parent
compounds from aqueous phase. Figure 4 showing the WWTP removal efficiency of the
most studied micropollutants in 14 countries/regions (data from Table 2) depicts compoundspecific variation in removal (12.5 to 100%). Compounds even in the same usage class were
14

removed to fairly different degrees. For individual compounds, location-specific large
elimination disparities were also displayed. For example, diclofenac was significantly
removed (81.4%) in a Korean WWTP (Behera et al., 2011) while it showed minor reduction
(5%) in a Spanish WWTP (Rosal et al., 2010). Generally, the removal difference among
different compounds in WWTPs could be ascribed to a number of factors such as
micropollutant properties and operational conditions.
The most investigated micropollutants in WWTPs were NSAIDs. Ibuprofen, naproxen
and ketoprofen exhibited moderate to high removal with average removal efficiency of
91.4%, 75.5% and 51.7%, respectively. In particular, the eliminations of ibuprofen were
relatively consistent and commonly higher than 70%. As opposed to other NSAIDs,
diclofenac experienced fairly inefficient (average 35.8%) and variable removals. The selected
antibiotics showed low (erythromycin, 30.2%) to moderate removal (sulfamethoxazole,
64.6%). Lipid regulators and β-blockers were also not efficiently eliminated (37.6%-73.3%)
in WWTPs. Anticonvulsant carbamazepine seemed to be the most persistent pharmaceutical
and was averagely reduced by only 32.7%. Among all the reviewed studies, the highset
removal of carbamazepine was observed by Choi et al. (2008a), reaching 62.3%. As
mentioned above, caffeine was the most abundant compounds present in municipal
wastewater. WWTPs proved to be effective in eliminating caffeine with an average removal
efficiency of 88.7%. In the case of PCPs, relatively high reductions were exhibited, ranging
between 74.2% (DEET) and 87.5% (galaxolide). As for steroid hormones, relatively stable
and high removal efficiency was observed, which ranged from 71.9-100%. Two surfactants,
nonylphenol and octylphenol, showed removals of 77.5% and 84.2%, repectively.
Contradictory results have been reported for the elimination of nonylphenoel, ranging from
21.7% (Stasinakis et al., 2008) to 99.0% (Janex-Habibi et al., 2009). The concentrations of
bisphenol A were commonly considerably lowered (82%) during wastewater treatment. Other
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selected industrial chemicals also showed removal efficiencies exceeding 80%. Due to the
fact that pesicides have been typically considered of agricultural rather than of urban origin,
few studies have been performed at real plant scale and most of reported plants coincide in
showing insufficient removal of pesticides (Köck-Schulmeyer et al., 2013). The selected
pesticides, such as atrazine, fluconazole and tebuconazole, were particularly resistant in
WWTPs.
It is difficult to draw a firm conclusion on the persistency of each compound, as many
compounds showed significantly varied removals in different WWTP. However, a simple
classification of these compounds is presented in Table 6.
Fig. 4.
Table 6

3.3 Factors governing the fate of micropollutants in WWTPs
The fate of micropollutants in WWTPs is under the control or influence of ‘internal
factors’ and ‘external factors’. Internal factors are micropollutant-related, including the
characteristics of micropollutants (e.g. hydrophobicity, biodegradability, and volatility). In
general, polar and non-volatile compounds are more likely to escape wastewater treatment
processes. External factors are WWTP-specific, which are linked to the treatment conditions
of wastewater treatment processes, the mixture of micropollutants that can act as competitors
and nature of wastewater (pH and temperature).

3.3.1 Micropollutant‐related factors
Sorption of a micropollutant to solids largely depends on the hydrophobicity of the
compound. The octanol-water partition coefficient (Kow) is frequently used to predict
absorption of micropollutants on solids. Rogers (1996) provided a general rule of thumb for
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applying KOW to the estimation of sorption: logKow < 2.5 indicates low sorption potential, 2.5
< logKow < 4 indicates medium sorption potential, and logKow > 4 indicates high sorption
potential.
Acidity determined by the functional group of a compound can play an important role in
chemisorption or/and electrostatic adsorption of micropollutants. Schäfer et al. (2011)
indicated that, at the pH above the acid dissociation constant (pKa), the phenolic hydroxyl
group of hormones dissociates and the compounds becomes negatively charged, facilitating
the charge repulsion with the negatively charged membrane. Charge repulsion can also be
expected to occur between negatively charged compounds and biomass in the activated
sludge reactors, thereby impeding the removal of micropollutants.
In activated sludge processes, the solid-water distribution coefficient (Kd) is defined as
the partition of a compound between the sludge and the water phase. Taking into
consideration both Kow and pKa, Kd has been proposed as a relative accurate indicator of
sorption behaviour (Ternes et al., 2004; Joss et al., 2005). For compounds having a Kd of
below 300 L/kg (log Kd < 2.48), the sorption onto secondary sludge can be considered to be
insignificant. Additionally, Tadkaew et al. (2011) reported that the studied micropollutants
with log Kd >3.2 (e.g. estrone and nonylphenol) were easily removed (>85%).
As biodegradability of micropollutants depends on their bioavailability, the first phase of
the biodegradation process is the uptake of micropollutants by cell, leading to by chance
affinity of the compound with the bacterial enzymes (Siegrist et al., 2005). Compound
structure also plays an important role in determining resistance of a micropollutant to
biodegradation. The biodegradability of a compound intrinsically relies on the complexity of
the compound (e.g. monocyclic or polycyclic) and its functional groups (e.g. halogen groups).
In general, the easily degraded substances include 1) linear compounds with short side chains,
2) unsaturated aliphatic compounds, and 3) compounds possessing electron donating
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functional groups. On the other hand, the persistent micropollutants contain 1) compounds
with long, highly branched side chains, 2) saturated or polycyclic compounds, and 3)
compounds possessing sulphate, halogen or electron withdrawing functional groups (Jones et
al., 2005; Tadkaew et al., 2011). Nevertheless, for some pharmaceutical compounds, there is
no obvious relationship among chemical structure, functional groups and the removal. For
example, two structurally similar compounds such as ibuprofen and ketoprofen could show
different removals, with ibuprofen being eliminated more efficiently (Camacho-Muñoz et al.,
2012).
Henry's law constant (kH) is commonly used to characterize the volatility of a compound.
The kH ranging from 10-2 to 10-3 mol/(m3·Pa) commonly indicates high tendency of
volatilization (Stenstrom et al., 1989). According to Suárez et al. (2008), volatilization of
micropollutants is totally negligible for pharmaceuticals and estrogens, nearly negligible for
fragrance compounds tonalide and galaxolide and very significant for celestolide.
Volatilisation was found to account for up to 16% of celestolide of the compound (Suárez et
al., 2010). Furthermore, in activated sludge processes, the volatilization behaviour can be
intensified due to the additional air supply.

3.3.2 WWTP-specific factors
Sludge retention time (SRT) controls the size and diversity of a microbial community.
Enhanced elimination of micropollutants can be achieved if the treatment processes have
extended SRTs, which facilitate the buildup of slowly growing bacteria, such as nitrifying
bacteria. In nitrifying conditions, co-metabolism using ammonium monooxygenase enzyme
is a possible degradation pathway for micropollutants. Nitrifying biomass have been found to
have positive effects on the removal of a range of micropollutants such as ibuprofen,
naproxen, fluoxetine, trimethoprim, roxithromycin, erythromycin, galaxolide, tonalide,
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ethinylestradiol, bisphenol A and nonylphenol. (Suárez et al., 2010; Fernandez-Fontaina et
al., 2012).
Clara et al. (2005) suggested that the SRTs allowing nitrogen removal (nitrification and
denitrification) above 10 days can enhance the elimination of some biodgradable compounds
(e.g. ibuprofen, bezafibrat, natural estrogens and bisphenol A). In a study, the activated
sludge treatment with an elevated SRT of 18 days could achieve considerably higher removal
of beta blockers and psycho-activate drugs in comparison with the same treatment with
shorter SRT of 0.5 days (Wick et al., 2009). Suárez et al., (2010) identified 10% higher of
removal efficiency for fluoxetine, citalopram and ethinylestradiol when prolonged SRT was
applied. Enhanced biodegradation was found for 4-n-nonylphenol and triclosan at SRT of 20
days (compared with 3 days and 10 days) (Stasinakis et al., 2010). However, high SRT does
not necessarily mean better removal performance. Joss et al. (2005) suggested that variation
of the sludge age between 10 and 60-80 days showed no noticeable effects on removal
efficiency of the investigated pharmaceuticals. High SRT (20 days) also seemed not to
appreciably affect the biodegradation of bisphenol A (Stasinakis et al., 2010). Santos et al.
(2009) indicated that application of low SRTs (1.5-5.1 days) had minor effects on the
removal of some pharmaceutical compounds (e.g., ibuprofen, diclofenac, naproxen, and
carbamazepine).
Hydraulic retention time (HRT) is the amount of time that allows for biodegradation and
sorption. The micropollutants having slow/intermediate kinetics such as fluoxetine or some
biotics will experience less effective biodegradation at shorter HRTs or increasing loading
rates (Fernandez-Fontaina et al., 2012)., Huang et al. (2008) indicated HRT in the range from
5 to 14 h achieved minor removal of DEHP, while higher HRT increased DEHP
accumulation in the system and DEHP retention in the waste sludge.
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Redox condtions may cause the observed differences by having an effect on certain
wastewater or sludge characteristics as wells as on the biodiversity of the microbial flora
present (Göbel et al., 2007). Qiang et al. (2013) indicated unfavourable redox conditions
(anaerobic conditions) could result in inefficient biodegradation of some micropollutants. In
another study, naproxen, ethinylestradiol , roxithromycin and erythromycin were found only
considerably eliminated under aerobic condtion and anoxic removal was much less effective
(Suárez et al., 2010). Zwiener and Frimmel (2003) compared short-term biodegradation of
clofibric acid, ibuprofen, and diclofenac in oxic and anoxic (denitrification conditions,
absence of oxygen while presence of nitrate) biofilm reactor. In oxic biofilm reactor, clofibric
acid and diclofenac were not eliminated, with only 1-4% loss of their initial concentration
being observed. Ibuprofen was reduced by 64–70%. By contrast, anoxic achieved much
lower removal of ibuprofen (17-21%) and higher removal of diclofenac (34%-38%) and
clofibric acid (26-30%). Goel et al. (2003) reported removal of the nonylphenol ethoxylate
surfactant was higher in the oxic reactors (50 to 70%) compared to the anoxic reactors (30 to
50%). Similarly, di-(2-ethylhexyl) phthalate were removed by 15%, 19% and 62% in
anaerobic, anoxic and aerobic reactors (Huang et al., 2008). Anoxic redox conditions were
not necessarily less favourable enviroments for micropollutant removal. For instance, anoxic
conditions could lead to improved elimination of iodinated X-ray contrast media, while
aerobic environments witnessed minor removal (Drewes et al., 2001). Some persistent
substances, diclofenac, sulfamethoxazole, trimethoprim and carbamazepine showed minor
removals (<25%) by the either biological treatment with neither nitrifying (oxic) or
denitrifying bacteria (anoxic) (Suárez et al., 2010).
Wastewater characteristics, such as pH and temperature, may have effects on
micropollutant removal. The acidity or alkalinity of an aqueous environment can vary the
elimination of micropollutants from wastewater by influencing both the physiology of
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microorganisms (pH optima of microbial enzyme activities) and the solubility of
micropollutants present in wastewater (Cirja et al., 2007). Kimura et al. (2010) found that
modest pH variation had significant effects on the removal of acidic pharmaceuticals
(clofibric acid, ibuprofen, ketoprofen, naproxen and mefenamic acid) by the biosolids, which
was presumably ascribed to activation of enzymes involved or enhancement of affinity
between the biosolids and pharmaceuticals due to protonation of acidic pharmaceuticals.
Seasonal variation of temperature may have impact on micropollutant removal in WWTPs.
Temperature variation can affect biodegradation and partition (sorption and volatilization) of
micropollutants. To eliminate the seasonal effect, alteration of operation parameters can be
taken into consideration. For example, a possible strategy to improve EDCs removal in the
cold temperature is to increase the mixed liquor suspended solids concentration by raising the
SRT (Nie et al., 2012). Generally, enhanced micropollutant removal can be achieved at
warmer temperature due to promoted microbial activities (Nie et al., 2012; Qiang et al.,
2013). Yet, Hai et al. (2011) found that operation at high temperature levels (45 ◦C) could
lead to lowermicropollutant removal. Some other studies showed micropollutant elimination
was independent of temperature fluctuation (Suárez et al., 2010).
4. Overview of treatment alternatives for micropollutant removal
No specific treatment is now available to assure the complete removal of various
micropollutants due to their diverse properties. Reliable processes that are able to eliminate
both bulk substances as well as micropollutants are yet to be developed. An overview of the
current treatment options is present in the following sections to reveal the performance of
each technique for micropollutant removal and to identify the need for improvement.

21

4.1 Coagulation‐flocculation
Coagulation-flocculation is used for removing particulate matter, colloids as well as
some dissolved substances. Table 7 presents some recent literature data regarding the
removal of the most studied micropollutants from wastewater by coagulation–flocculation
processes. In general, coagulation-flocculation processes yield ineffective elimination of most
micropollutants. Matamoros and Salvadó (2013) evaluated the micropollutant removal in a
coagulation/flocculation – lamellar clarifier for treating secondary effluent. The removals
ranged from imperceptible elimination to 50%, among which the relatively high removals
(20-50%) were observed for the compounds with KOW > 4 at pH = 7-8 (e.g. galaxolide,
tonalide, and octylphenol). Suárez et al. (2009) reported significant reduction (around 80%)
of musks (e.g. galaxolide and tonalide) during coagulation-flocculation treatment of hospital
wastewater. The other compounds that showed identifiable elimination were diclofenac (max.
46%), naproxen (max. 42%) and ibuprofen (max. 23%). Since landfill leachate has been
considered as an important source of some EDCs, Asakura and Matsuto (2009) pointed out
that coagulation and sedimentation was not able to remove biphenol A but achieved much
higher removals for DEHP and nonylphenol (70% and 90% respectively) thorugh leachate
treatment processes.
Table 7

As a whole, most micropollutants, as shown above, have been reported to be poorly
removed during coagulation-flocculation processes. Exceptions were some musks, a few
pharmaceuticals (e.g. diclofenac) and nonylphenol due to their high KOW (4-6). Besides,
neither coagulant dose nor operation temperature influenced the removal of pesticides
significantly (Thuy et al., 2008). Despite the minor differences among different types of
coagulants at different doses, Suárez et al. (2009) reported that the addition of 25 mg/L FeCl3
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achieved optimal results in most cases. Huerta-Fontela et al. (2011) demonstrated that
aluminium sulphate was effective in eliminating some hydrophobic pharmaceutical
compounds. Composition of wastewater can exert either positive or negative effects on
micropollutant removal during coagulation-flocculation treatment. For example, high fat
content in water source was reported to improve the removal of hydrophobic compounds
(Suárez et al., 2009). Dissolved humic acid could also enhance the elimination of some
pharmaceutical compounds, such as diclofenac, ibuprofen and bezafibrate (Vieno et al.,
2006). On the contrary, the presence of dissolved organic matters (DOM), especially lowmolecular-weight fractions, can possibly inhibit the micropollutant removal due to the
preferential removal of DOM through coagulation. Negatively charged DOM could react
with positively charged aluminium hydrolysis species, leading to a less amount of coagulant
available for elimination of the compounds (Choi et al., 2008b). In addition, the performance
of coagulation-flocculation processes can be also governed by several operating conditions
including mixing conditions, pH, alkalinity, temperature as well as the presence of divalent
cations and concentrations of destabilizing anions (e.g. biocarbonate, chloride, and sulphate)
(Alexander et al., 2012).

4.2 Activated carbon adsorption
Adsorption by activated carbons (ACs) is commonly employed for controlling taste and
ordor in drinking water. This technique also has great potential for treatment of secondary
effluent and has proved to be more effective in removing micropollutants in comparison with
coagulation-flocculation process (Choi et al., 2008b). Both powdered activated carbon (PAC)
and granular activated carbon (GAC) have been widely used in adsorption processes (Table
8), which can be affected by the properties of both adsorbate (KOW, Pka, molecular size,
aromacity versus aliphaticity, and presence of specific sunctional groups) and adsorbent
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(surface area, pore size and texture, surface chemistry, and mineral matter content) (Kovalova
et al., 2013).
Table 8

4.2.1 PAC
PAC has been considered as an effective adsorbent for treating persistent/nonbiodegradable organic compounds. An advantage of employing PAC is that it can provide
fresh carbon continuously or can be used seasonally or occasionally when risk of trace
organics is present at a high level (Snyder et al., 2007). Kovalova et al. (2013) investigated
elimination of micropollutants from a MBR-treated hospital effluent using PAC treatment at
a retention time of two days. With PAC doses of 8, 23 and 43 mg/L and retention time of 2
days, the PAC reactor achieved efficient elimination for most of the micropollutants
(pharmaceuticals, metabolites and industrial chemicals). The reduction of total load of
selected pharmaceuticals and metabolites was around 86%. Batch tests performed by
Hernández-Leal et al. (2011) also demonstrated marked removal (>94%) of various
micropollutants (personal care products, bisphenol A and nonylphenol) during PAC treatment
with initial compound concentrations of 100-1600 µg/L at a dose of 1.25 g/L and a contact
time of five minutes.
PAC addition in activated sludge tank or post treatment configurations is a major
application of PAC in the full-scale municipal WWTPs. A study was carried out to assess the
efficiency of micropollutants (PPCPs) removal by addition of PAC in different flow schemes
in municipal wastewater treatment (Boehler et al., 2012). It was found that counter-current
use of PAC by recycling waste PAC from post-treatment tank to biological treatment tank
could enhance micropollutant removal by 10 to 50% in comparison with the application
without recycling. PAC addition in WWTPs was shown to be able to reduce micropollutant
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levels by more than 80%. The PAC dosage for adequate treatment of secondary effluent with
dissolved organic carbon (DOC) of 510 mg/L was 1020 mg/L, while a higher amount (30–
40 g/m3 influent) was required to achieve similar results if direct PAC addition was employed
in biology tank.
The performance of PAC in eliminating micropollutants depends upon PAC dose and
contact time, the molecular structure and behavior of the targeted compound, as well as the
water/wastewater composition (Snyder et al., 2007; Boehler et al., 2012). Either higher dose
or longer contact time can probably result in greater removal of micropollutants. Westerhoff
et al. (2005) revealed micropollutant removal was improved with higher PAC dosages (20
mg/L) and independent of the initial compound concentrations. Water/wastewter composition
also affects the adsorption of micropollutants. The sorption efficiency of PAC could be
reduced as the DOC content increases (Boehler et al., 2012). Despite the influence of other
contaminants in wastewater, the efficacy of applying PAC to wastewater for micropollutant
removal is comparable with that of ozonation. Thus, PAC addition appears an attractive
method for upgrading municipal WWTPs for improved micropollutant removal (Bolong et al.,
2009).

4.2.2 GAC
Rossner et al. (2009) suggested that GAC dosage typically applied to taste and odour
control in drinking water (<10mg/L) was sufficient to provide a 2-log removal for most of
various compounds in a lake water. Hernández-Leal et al. (2011) evaluated the effectiveness
of GAC in treating two wastewaters: (1) spiked (0.1-10 µg/L) aerobic effluent in a GAC
column operated at low flow and (2) aerobic effluent with real concentrations (40 ngL/L to
7.9 µg/L) of micropollutants in a GAC column. In the first case, removals for all the
compounds were generally high (>67%), particularly for ethyl-, propyl- and butylparaben,
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triclosan, caffeine, BP3, PBSA and 4MBC (>90%). In the second case, most compounds
were also effectively eliminated. Specifically, the removal efficiency ranged from 50%
(tonalide and nonylphenol) to more than 90% (galaxolide and PBSA).
A full-scale granular activated carbon plant treating a WWTP effluent was assessed in
terms of the removal efficiency of steroidal estrogens and pharmaceuticals (Grover et al.,
2011). Considerable removals of steroidal estrogens from sewage effluent were observed
during the GAC tertiary treatment. By comparison, the reduction of pharmaceutical
concentrations was more variable. For example, higher removals (84-99%) were observed for
mebeverine, indomethacine, and diclofenac, while some compounds (e.g. carbamazepine and
propranolol) displayed much less removals (17-23%). In spite of the efficient treatment of
sewage effluent, GAC-based removal technology should be carefully operated, as the
efficiency will decrease over time due to the saturation of adsorption site.
Similar to PAC, the contact time is a major factor that affects the degree of adsorption.
Short contact time is likely to lead to significant lowered adsorption efficiency. As the
elimination of the trace contaminants depends largely upon particle-contaminant interactions,
the competition for adsorption sites and/or pore blocking (by particle solids) can reduce the
removal efficiency of activated carbon (Bolong et al., 2009). Thus, GAC tends to perform
poorly if wastewaters are highly contaminated. Snyder et al. (2007) suggested that a steamtreated GAC could be employed to overcome the drawbacks of GAC due to its greater
absorption capacity. Regular regeneration of GAC also seemed of vital importance to
maintain minimal breakthrough of micropollutants. Furthermore, pore shape/size and
volumes of activated carbons, carbon type, surface charge of compounds and operation year
were noted to have influence on the removal performances (Choi et al., 2008b; Rossner et al.,
2009):
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 Broader micropore size distribution of the GAC led to more efficient adsorption of
compounds with different shapes and sizes;
 Pore volume was important to adsorption capacity rather than specific area; larger pore
volume was commonly associated with greater removal efficiency.
 Negatively charged micropollutants were likely to be poorly adsorbed by the negatively
charged carbon and well adsorbed by the positively charged carbon;
 Adsorption capacity reduced with operation year.
From the aforementioned studies, GAC and PAC appear attractive methods for
micropollutant removal. In general, efficient removal is potentially achievable when the
compounds have non-polar characteristics (Kow>2) as well as matching pore size/shape
requirements (Rossner et al., 2009; Verlicchi et al., 2010b). However, activated carbon
efficacy might be significantly lowered by presence of natural organic matter which competes
for binding sides, thereby resulting in blocked pores. Besides, PAC dose, GAC regeneration
as well as contact time play important roles in efficient removal of micropollutants.

4.3 Ozonation and advanced oxidation processes (AOPs)
Due to the refractory nature of some micropollutants, conventional physicochemical and
biological treatments are not able to provide adequate elimination of these compounds. To
overcome the problem, ozonation and AOPs can be considered. Performance of these
processes in micropollutant removal is reported in Table 9. Ozonation and AOPs are efficient
redox technologies which demonstrate some superiority over conventional treatments, such
as high degradation rates and non-selectivity. Moreover, these processes have disinfecting
effects, which are essential for reuse applications that involve direct human contact, e.g.,
household reuse applications (Hernández-Leal et al., 2011). Ozone can degrade contaminants
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directly and indirectly (mainly via formation of stronger and less selective oxidising agent,
•OH). Some micropollutants are susceptible to both ozone and AOPs (e.g., naproxen and
carbamazepine), whereas some are only subject to •OH (e.g. atrazine and meprobamate) and
some are resistant to both forms of oxidation (e.g. TCEP and TCPP) (Gerrity et al., 2011).
The generation of •OH can be promoted with the presence of H2O2, Fenton reagent and
ultraviolet.
Table 9

Hernández-Leal et al. (2011) examined the efficiency of ozonation for the removal of a
wide range of micropollutants (UV-filter, fragrance, biocide and surfactant) from biologically
treated grey water. In general, all the compounds were significantly removed (>79%) from
the biologically treated effluent at an applied ozone dose of 15 mg/L. In another study, lower
ozone dose of 5 mg/L also showed high removal efficiency for most of the targeted
micropollutants (Sui et al., 2010). The concentrations of carbamazepine, diclofenac,
indomethacin, sulpiride and trimethoprim were considerably reduced by more than 95%. The
reductions of DEET and metoprolol were modest. By contrast, bezafibrate was very resistant
to ozonation and was removed by only 14%.
A study conducted by Gerrity et al. (2011) focused on the application of O3/H2O2 for
removing a suite of micropollutants (PPCPs and steroid hormones) during water reclamation.
The process showed considerable removal efficiency (>90%) for almost all of the target
contaminants, except TCEP (13%), TCPP (26%), atrazine (69%), meprobamate (80%), and
ibuprofen (83%). They indicated that micropollutants which exhibited the highest levels of
oxidation were characterized by high ozone and •OH rate constants associated with their
electron-rich moieties (e.g., phenols, anilines, olefins and activated aromatic). Although the
formation of •OH was enhanced under alkaline conditions, Zhang et al. (2012) reported lower
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pH was beneficial for EDCs removal by ozone when treating synthetic secondary effluent.
This is because ozone was less reactive to the inorganic and organic matters (non-target
compounds) in the synthetic secondary effluent as compared to •OH (generated at high pH)
and a greater amount of O3 could thereby be preserved for the reactions with target
compounds. Furthermore, in spite of the fact that suspended sludge particles could lead to
higher O3 consumption, which might reduce the efficiency of ozonation for micropollutant
removal, this effect was not significant and had only a minor impact on ozonation as well as
oxidation by •OH at low O3 dosages (Huber et al., 2005; Hernández-Leal et al., 2011).
Kim et al. (2009b) examined the effectiveness of UV (wave length: 254mm)-based
processes (UV and UV/H2O2) for the elimination of 41 pharmaceutical compounds. UV alone
could significantly remove (>90%) only a few compounds (e.g. ketoprofen, diclofenac and
antipyrine) while ineffective removals (24%-34%) were observed for macrolides. By
contrast, with the addition of H2O2 (7.8 mg/L), the process considerably improved its efficacy
and removal efficiency increased up to 90% for 39 out of 41 compounds. Treatment of 32
selected micropollutants (pharmaceuticals, corrosion inhibitors and biocides/pesticides) in an
effluent coming from a municipal activated sludge WWTP was also investigated using UV
(wavelength: 254 nm), UV/H2O2, Fenton (Fe2+,3+/H2O2) and photo-Fenton (Fe2+,3+/H2O2/UV
and Fe2+,3+/H2O2/simulated sunlight) (De la Cruz et al., 2012). The process with only UV
irradiation yielded a global degradation of 46% for the micropollutants after 10min. Four
compounds (diclofenac, ketoprofen, memfenamic acid and diuron) were completed removed
during the process. In contrast, the concentrations of gabapentin, trimethoprim, metformin,
primidone, azithromycin and clarithromycin were unaltered or only slightly reduced (<10%).
Comparing with UV treatment alone, UV and H2O2 (50 mg/L) exhibited elevated
transformation (a total degradation of 81%) of the micropollutants. After 30 min of UV/H2O2,
the transformation increased further up to 97%. Fenton process (5 mg/L Fe2+, 3+/ 50 mg/L
29

H2O2) achieved 31% degradation. It was able to completely eliminate only one of the
micropollutants, norfloxacin, after 30 min, and the concentrations of ten compounds were
reduced by less than 15%. When UV was applied to the process (under the same conditions
mentioned above), significantly increased global degradation (97%) was observed. For the
photo-Fenton process, either increased H2O2 dosage or extended reaction time was found to
have positive impact on the global degradation. Fenton/UV254 (100% degradation after 90
min) displayed much higher degradation efficiency compared with Fenton/sunlight (47%
degradation after 90 min). In addition, the presence of dissolved organic matter in the
wastewater seemed to enhance the micropollutant removal during all the processes. In
another study, Klamerth et al. (2010) reported much higher efficiency of photo-Fenton with
solar light for treatment of 52 micropollutants (PPCPs and pesticides) in a WWTP effluent.
The process was able to degraded 48 compounds below their limit of detection.

4.4 Membrane processes
Table 10 presents some recent research data concerning the effectiveness of membrane
technology in eliminating micropollutants. The retention of micropollutants in membrane
processes can generally achieved by size exclusion, adsorption onto membrane, and charge
repulsion. These removal mechanisms are largely dependent on a number of factors, such as
membrane process type, membrane characteristics, operating conditions, specific
micropollutant characteristics and membrane fouling (Schäfer et al., 2011).
Table 10

Although Microfiltration (MF) and Ultrafiltration (UF) are proved processes to
efficiently eliminate turbidity, micropollutants are generally poorly removed during UF and
MF, as the membrane pore sizes are much larger than the molecular sizes of micropollutants.
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However, micropollutants can be removed via adsorption on to membrane polymers, as well
as interaction with natural organic matter (NOM) in wastewater. Jermann et al. (2009)
examined the fate of ibuprofen and estradiol during an UF process and the effects of fouling
by NOM. Without NOM, UF with hydrophilic membrane showed insignificant removal for
ibuprofen and low (8%) removal for estradiol, while hydrophobic membrane retain much
larger amount of estradiol (up to 80%) and ibuprofen (up to 25%). The higher retention of
estradiol was due to the higher Carbon-Water Partitioning Coefficient (Koc) value of the
compound. As for the effect of NOM, NOM substances of high molecular weight such as
alginate and Aldrich HA showed a greater effect than the lower molecular weight Nordic
aquatic humic acid on enhancing micropollutant removal. Due to the low removal efficiency,
MF or UF alone is not feasible for micropollutant removal. Hence, the combination of MF or
UF with other processes (e.g. NF or RO) is essential for enhanced elimination of different
micropollutants. Garcia et al. (2013) combined MF with RO to remove micropollutants for
municipal wastewater reuse. MF was found to be able to reduce the concentrations of some
compounds, such as bis-(2-ethylhexyl) phthalate, by more than 50%. With the incorporation
of RO, the removal efficiency was significantly improved, ranging from 65% to 90% for
most micropollutants (except ibuprofen and nonylphenol). Similarly, a tertiary MF/RO
treatment process exhibited very efficient retention (>95%) of most of the studied PPCPs,
except mefenamic acid and caffeine (Sui et al., 2010).
In comparison with MF and UF, nanaofiltration (NF) and reverse osmosis (RO) have
much “tigher” structures. NF and RO are widely used in water reuse industry due to their
high contaminant removal efficiency. However, NF and RO membranes are still somewhat
permeable to some relatively small micropollutants (Steinle-Darling et al., 2010).
Röhricht et al. (2009) investigated two different types of submerged NF flat sheet
modules for the removal of pharmaceuticals from WWTP effluent. Naproxen and diclofenac
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(60%) were retained to a greater extent compared with carbamazepine (slight removal). At
pH 7 and 8, naproxen and diclofenac (with pKa values of 4.2 and 4.15, repectively) were
deprotonated, while carbamazepine (pKa=13.9) was not. Hence, naproxen and diclofenac
could be rejected by the negatively charged membrane surface, whereas carbamazepine could
not be removed. This was in accordance with the viewpoint indicated by Schäfer et al. (2003)
and Nghiem et al. (2005): the speciation of pharmaceuticals may result in a significant
change in rejection as a function of pH, with much greater retention occurring for ionized,
negatively

charged

pharmaceuticals.

For

uncharged

pharmaceuticals,

intrinsic

physicochemical properties of the pharmaceutical molecules play a role in their retention.
Apart from electrostatic repulsion, adsorption can serve as the overriding removal mechanism
in some cases. This was demonstrated in a study evaluating the removal of a variety of
EDC/PPCPs using UF or NF (Yoon et al., 2006). For more polar compounds, the NF
membrane (44–93% removals except naproxen of no rejection) was more efficient than the
UF membrane with typical removals of less than 40% except a few compounds (triclosan,
87%; oxybenzone, 77%; progesterone, 56%). By contrast, for the less polar compounds,
many permeate EDC/PPCP concentrations (14 out of the 25 compounds) were below
detection, suggesting high removal efficience by both NF and UF membranes except for a
few compounds (α- and β-BHC, fluoranthene, hydrocodone, metolachlor, and musk ketone).
Better performance was also observed for NF.
RO generally shows great potential to partially or significantly remove micropollutants.
Sahar et al. (2011) applied RO after CAS-UF and MBR processes and assessed its efficiency
in eliminating micropollutants. The two processes, CAS-UF/RO and MBR/RO, showed
relatively similar and high elimination efficiencies: >99% for macrolides, pharmaceuticals,
cholesterol and BPA, 95% for diclofenac, 97% for SMX, and >93% for both SMZ and TMP.
Despite the highly effective RO treatment, 28-223 ng/L residuals of ibuprofen, diclofenac,
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salicylic acid, cholesterol, and BPA were detected in the permeates from both units. This
elucidated that RO was not an absolute barrier for micropollutants. Yangali-Quintanilla et al.
(2011) compared the various micropollutants (pharmaceuticals, pesticides, endocrine
disruptors and others) removal by NF and RO. The elimination efficiency of NF membranes
was very close to that achieved by RO membranes. The average retention efficiency by tight
NF was 82% for neutral contaminants and 97% for ionic contaminants, while RO was able to
achieve 85% removal of neutral contaminants and 99% removal of ionic contaminants.

4.5 Membrane bioreactor
Membrane bioreactor (MBR) process combine activated sludge biological treatment and
membrane filtration (MF and UF). MBRs possess the following advantages over
conventional wastewater treatment in the following aspects (Ngo et al, 2012) such as high
effluent quality. excellent microbial separation ability, absolute control of SRTs and HRTs,
high biomass content and less sludge bulking problem, low-rate sludge production, small
footprint and limited space requirement, and possibilities for a flexible and phased extension
of existing wastewater treatment plants (WWTPs).
MBRs are able to effectively remove a wide spectrum of micropollutants including
compounds that are resistant to activate sludge processes (Radjenovic et al., 2009). This is
because 1) They are able to retain sludge to which many compounds are adhered; 2) The
membrane surface can also intercept the compounds; 3) The longer SRT in MBRs may
promote microbial degradation of the compounds (Spring et al., 2007). Table 11 summarizes
some recent studies involving MBR processes. The removal of micropollutants in MBR can
be affected by a number of factors, such as sludge age and concentration, existence of anoxic
and anaerobic compartments, composition of the wastewater, operating temperatures, pH and
conductivity (Kovalova et al., 2012).
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Table 11

Trinh et al. (2012) investigated the micropollutant removal efficiency of a full-scale
MBR. High elimination (>90%) was observed for most of the micropollutants. Nevertheless,
some compounds were incompletely
carbamazepine,

diazeoam,

removed (24-68%), including amitriptyline,

diclofenac,

fluoxetine,

gemfibrozil,

omeprazole,

sulphamethoxazole and trimethoprim. Hence, these compounds were considered as potential
indicators for evaluating the micropollutant removal using MBR processes. Generally,
hospitals are the major source of many pharmaceuticals released into the environement
(Verlicchi et al., 2010a). A pilot-scale MBR was employed for on-site treatment of hospital
effluent (Kovalova et al., 2102). In this study, they elucidated that the concentrations of
investigated compounds in the hospital wastewater were considerably different from those in
municipal wastewater. For instance, average 32 μg/L of the antibiotic ciprofloxacin and up to
2600 μg/L of iodinated X-ray contrast media were detected in the hospital wastewater, which
was around 70-time higher than those observed in the municipal wastewater. In addition,
higher concentrations of antibiotics and disinfectants due to large amounts of usage in
hospitals could lead to bacterial inhibition during the on-site treatment. The overall
recucation of all pharmaceuticals and metabolites was only 22%, as a large fraction (80%) of
the feed was persistent iodinated contrast media. However, if the iodinated contrast media
were not taken into account, the reduction would be up to 90%. Full-scale MBR studies for
hospital wastewater treatment were also investigated by Beiber et al. (2011), which suggested
that separation of rainwater collection and water streams with low pharmaceutical
concentrations, and maintenance of sludge age > 100 days should be considered in the design
of MBR for hospital wastewater.
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Both being cost effective technologies in wastewater treatment, MBR processes and
conventional activated sludge (CAS) processes have been frequently compared in terms of
their performance in micropollutant removal. Radjenovic et al. (2007) compared the removal
of several pharmaceutical products in a laboratory scale MBR and a CAS process. Both
systems were effective in removing some compounds (e.g., naproxen, ibuprofen,
acetaminophen, hydrochlorothiazide, and paroxetine). However, the results presented that
pharmaceuticals showed greater and steadier elimination during MBR process (>80% in most
cases). Another comparative investigation of MBR and CAS process was performed by Chen
et al. (2008). Similarly, MBR was slightly more efficient in micropollutant removal. The
efficiency of elimination in the MBR appeared stable regardless of changes in sludge loading
and HRT.
Biological treatment combined with membrane filtration (MF or UF) are also employed
for treating wastewater. Sahar et al. (2011) compared the removals of several macrolide,
sulphonamide and trimethoprim antibiotics from raw sewage using a full-scale CAS system
coupled with a subsequent UF filtration (CAS-UF) and a pilot scale MBR. Antibiotics
removal in the MBR system was generally higher than that in the CAS-UF system. The
elimination of Trimethoprim, sulfamethoxazole and erythromycin was 99%, 70%, 61% in the
MBR system, and 45%, 52% and 71% in the CAS-UF system, respectively. It was assumed
that antibiotics removal in both systems was due either to sorption to biomass (rather than
biological transformation) or to enmeshment in the membrane biofilm (as the pore size of UF
is significantly larger than the antibiotic molecules).
Recently, membranes in conjunction with anaerobic reactors have been gaining
popularity due to their intrinsic advantages over aerobic systems, such as low sludge
production, net energy generation and a fully enclosed environment (Hu and Stuckey, 2006).
The applications of anaerobic MBRs for micropollutant removal have been investigated in
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some recent studies (Xu et al., 2008; Abargues et al., 2012). A pilot-scale submerged
anaerobic MBR (SAnMBR), a conventional activated sludge (CAS) unit and a pilot-scale
aerobic MBR were evaluated for removing some alkylphenols (APs) and hormones
(Abargues et al., 2012). The observed concentrations of APs in the SAnMBR effluent were
consistently at significantly higher levels than those in the permeates from other units,
indicating the ineffective removal of APs by SAnMBR.
During MBR processes, several operational parameters (e.g. SRT, HRT and
temperature) can influence the reduction of micropollutants. In general, MBRs have high
SRTs, thus diverse microorganisms, including some slow growing bacterial, can reside in the
reactors. When biomass is rich in nitrifying bacterial, higher biodegradation efficiency for
certain micropollutants can be achieved (Roh et al., 2009). De Gusseme et al. (2009) reported
a high elimination (99%) of 17α-ethinylestradiol (at initial concentration of 83 ng/L1) when a
nitrifier enrichment culture was applied in a MBR. The degradation of micropollutants by
nitrifying bacteria has also been evaluated in other types of systems (e.g., activated sludge
and fixed bed reactor) (Batt et al., 2006; Forrez et al., 2009; Zhou and Oleszkiewicz, 2010). A
general conclusion drawn from these studies is that nitrifying conditions have positive effects
on micropollutant removal. Temperature variability has been linked to decrease in bulk water
quality parameters and unreliability of system, as microbial growth and activity as well as
solubility and other physicochemical properties of organics are significantly affected by
temperature (Hai et al., 2011). Effects of temperature variation were explored in a lab-scale
MBR treating wastewater containing selected micropollutants (Hai et al., 2011). Both
hydrophobic compounds (log D > 3.2) and less hydrophobic compounds (log D < 3.2)
showed reduced elimination at 45C, which was ascribed to disrupted metabolic activity
typically linked to such elevated temperature. The removal of hydrophobic compounds was
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unaffected in the temperature range of 10–35C, while a relatively more obvious variation
was found in the removals of less hydrophobic compounds.

4.6 Attached growth treatment processes
Attached growth technology is a promising alternative to activate sludge processes for
wastewater treatment which involves attached growth on inert carriers either fixed or
mobilised in suspension of the reactor. The attached growth processes offer the following
advantages over activated sludge processes in wastewater treatment (Guo et al., 2012):
 They have better oxygen transfer, high nitrification rate and higher biomass

concentrations;
 They are more effective in organic removal, and can apply for high organic loading

rates at relatively shorter HRT;
 They allow the development of microorganisms with relatively low specific growth

rates (e.g., methanogens);
 They are less subject to variable or intermittent loadings;
 They are suitable for small reactor size, with space requirement being considerably

lower than that for AS; and
 For fixed-bed biofilm processes such as trickling filters and rotating biological

contactors (RBCs), the operational costs are lower than that for AS.
The attached growth systems can be grouped into two major groups: fixed bed
bioreactors (e.g. biofiltration) and moving bed bioreactors. Table 12 presents the
effectiveness of different attached growth processes in micropollutant removal.
Table 12
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Biofiltration seems a compelling biological technique for micropollutant removal
(Reungoat et al., 2011). Commonly used systems in water and wastewater treatment include
trickling filter, sand filtration and biological activated carbon (BAC). A BAC filter is
typically composed of a fixed bed of GAC serving as the carrier for bacterial adhesion and
growth. Reungoat et al. (2011) evaluated and compared the performance of biofilters with
two media, activated carbon and sand, during long-term operation. The results demonstrated
that BAC had a great potential for PPCPs (e.g. diclofenac, carbamazepine, sulfamethoxazole
and gemfibrozil) removal (> 90%) and reduction of the potential risk of environmental and/or
human health impact. On the other hand, sand filters could only achieve limited elimination
for PPCPs. Dissolved oxygen was the main factor affecting the performance of BAC filters,
while empty-bed contact time (from 30 min to 120 min) did not result in considerable
variation in the removals of compounds. In addition, long-term observation indicated that the
main mechanism for organic matter and PPCP removal in biofiltration was biodegradation
rather than adsorption. Another biofilter, namely sequencing batch biofilter granular reactor
(SBBGR), was investigated by Balest et al. (2008) for removing several selected EDCs. The
results showed that SBBGR achieved much higher removal efficiency for EDCs removal than
the conventional activated sludge process in a municipal WWTP. The removal effiencies for
bisphenol A, estrone, estradiol and 4-tert-octylphenol were 91.8%, 62.2%, 68% and 77.9%
for the demonstrative SBBGR system and 71.3%, 56.4% 36.3% and 64.6% for the
conventional activated sludge process of the municipal WWTP, respectively. The excellent
performance of the SBBGR was attributed to the very high sludge age (about 160 d). Due to
the excellent performance, biofiltration was suggested as an efficient treatment method that
could be employed in advanced treatment processes for reducing the impact of the effluent
discharge into the environment and/or providing water of higher quality for reuse.
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The biological removal of 17α-ethinylestradiol in an aerated submerged fixed bed
bioreactor was evaluated with or without ammonium starvation (Forrez et al., 2009).
Excellent removal (96%) was obtained at a volumetric loading rate of 11 µg/Ld of 17αethinylestradiol, slightly lower elimination rates (81 and 74% respectively) was reported
when increasing the loading rate up to 40 and 143 µg/Ld of 17α-ethinylestradiol. The authors
suggested that implementation of retro-fitting treatment systems, either by employing a posttreatment reactor containing separately grown ammonia-oxidizing bacterial (AOB) or by
continuously seeding the WWTP effluent with AOB grown in a dedicated reactor has great
potential for the removal of some micropollutants (Forrez et al., 2009). In another study using
a fixed film activated sludge (IFAS) to treat effluent estrogenic activities, Kim et al. (2009a)
found the effluent estrogenic activities in the IFAS system were 70% lower than those in the
control train (conventional activated sludge system), which suggested a high estrogen
removal by IFAS.
Falås et al. (2012) conducted a set of batch experiments to evaluate the effectiveness of a
hybrid moving bed biofilm activated sludge process for the removal of various
micropollutants. It was indicated that the presence of carriers could enhance the overall
biological elimination of some compounds. For example, diclofenac, clofibric acid and
mefenamic acid were not eliminated in the activated sludge reactors, while the carrier
reactors showed more obvious and rapid removals (at least 60% after 24 h) of the three
compounds. In another study, a moving bed biofilm system was investigated in terms of the
removal efficiency for bisphenol A, oseltamivir and atrazine from wastewater using carriers
made from existing bioplastic-based products (Accinelli et al., 2012). During the experiments
with control wastewater samples, mineralization rates for bisphenol A, oseltamivir and
atrazine were relatively low, accounting for only 18%, 7% and 3.5% of the initial
concentrations, respectively. By contrast, the addition of incubated carriers enhanced the
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removals of bisphenol A, oseltamivir and atrazine by 34%, 49% and 66%, respectively. Li et
al. (2011) focused their study on simultaneous PAC adsorption within a MBR. During the
treatment, PAC could not only act as an adsorbent but also provided support for biomass
growth. With a high PAC dosage of 1.0 g/L, enhanced elimination of sulfamethoxazole and
carbamazepine was observed in the PAC-amended MBR system (82% and 92% respectively)
in comparison with the MBR system alone (both 64%).
As a whole, although attached growth systems have not been applied broadly and
specifically to for micropollutant removal , the results from some recent bench-scale or pilot
scale studies showed that attached growth treatment processes are promising methods for
reducing discharges of micropollutants. By addition of packing/moving carriers, increased
microbial community can be maintained in the system, which facilitates the growth of slowgrowing microorganisms for micropollutant removal (Serrano et al., 2011). Therefore,
micropollutant removal by attached growth processes is a strategy showing possibility of
excellence and likely to draw more attention in the future research.

5.

Assessment

of

micropollutant

removal

from

municipal

wastewater

and

recommendation for future research
Micropollutants have been frequently detected in wastewater as well as important
drinking water sources, such as rivers, lakes and groundwater. The evaluation of
micropollutants from municipal sewage should cover a series of issues from sources to end
uses, including selection of micropollutants with high occurrence and ecotoxicological
relevance, determination of possible sources, investigation on their occurrence and fate in
WWTPs and receiving waters, and estimation of their (eco)-toxicological impacts on aquatic
systems and humans.
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The major types of wastewater media that convey micropollutants to aquatic systems via
WWTPs consist of domestic wastewater, hospital effluents, industrial wastewater and
stormwater runoff, rural runoff and manure. Intense efforts have been taken to investigate
domestic wastewater, while less focus has been put on other types of wastewaters which may
also have significant micropollutant loads. For example, hospitals are a considerable source
of various pharmaceuticals, including compounds generated from diagnostic, laboratory and
research activities as well as pharmaceutical excretion by patients (Verlicchi et al., 2010b).
Industrial practices (e.g. production of various commodities) can probably lead to a
remarkable discharge of micropollutants, especially EDCs, due to the use or/and formation of
the compounds during the production processes. The assessment of the significance for
different sources can be based on the compilation of literature data (Pal et al., 2010). Scale of
consumption or production (e.g. annual per capita consumption) of commodities containing
micropollutants can also be used as an indicator for micropollutants emission. Zhang et al.
(2008) suggested that the worldwide annual per capita consumption of drugs is 15 g and
developed countries contribute three to ten times higher (50-150 g).
Since WWTPs are not able to provide a complete barrier for micropollutant removal,
establishing optimal removal strategies for micropollutants remains a challenge to
environmental engineers in order to minimize their adverse effects on the environment.
Conventional treatment processes have been reported to have inadequate removals of many
micropollutants. Several potential options are available for improving the elimination of
micropollutants, including source controls (e.g. application of micropollutant-free products,
source separation, pretreatment of hospital and industrial effluents, etc.), reassessment and
optimization of current treatment processes, and end-of-pipe upgrading of WWTPs. As
mentioned above, the removal of highly persistent/non-biodegradable/polar micropollutants
is commonly low and independent of operating parameters during biological treatment
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processes, thereby exceeding the capacity of current treatment processes. Hence, tertiary (e.g.
post ozonation, sand filtration, and membrance filtration) or combined treatment processes
should be taken into consideration to ensure successful treatment of the variety of
micropollutants. Table 13 compares the micropollutant removal efficiency of three types of
WWTPs, namely low-cost, conventional and advanced WWTPs. Low-cost treatment
processes, such as trickling filter beds, lagooning and constructed wetland, are normally used
for decentralized wastewater treatment for small communities and in a few cases applied in
centralized WWTPs for large communities. As can be seen in Table 13, WWTPs with lowcost treatment processes exhibit comparatively low efficiency, while WWTPs with tertiary
treatments show more efficient and consistent removal of the compounds. Camacho-Muñoz
et al. (2012) concluded that most of the pharmaceutical compounds they studied were slightly
better removed in conventional treatment processes, which could be attributed to the better
aeration condition that led to more effective aerobic degradation. Meanwhile, the lowest
removal efficiency for some compounds (carbamazepine, propranolol and estriol) occurred in
lagooning compared with other conventional treatments and could be ascribed to the low
organic content of wastewater as well as the low amount of solids and poor aeration.
Nevertheless, the differences between the mean removal rates in conventional (64%) and
low-cost (55%) WWTPs were not significant. RO as a tertiary treatment showed 100%
removal for COD and selected EDCs, but the elevated energy consumption is a consistent
disadvantage (Balabanič et al., 2012). Salgado et al (2012) assessed a full-scale WWTP
employing UV as the post-treatment for PPCP removal. They evaluated the relevance of each
removal mechanism for the overall PPCP removal and indicated that the removal fractions
from biodegradation, sorption and UV are 45%, 33% and 22% respectively. Although UV
only accounted for 22% of the total removal, it was considered as an important effluent
polishing process.
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Table 13

Table 14 summarizes the advantages and disadvantages of different treatment techniques
reviewed. The provided information is based on the recent literature and may be helpful to
select suitable techniques for micropollutants treatment. However, the table only gives the
qualitative assessment of these techniques. Comprehensive quantitative assessment is needed
in future research to better compare different techniques from both economic and technical
points of view.

Table 14

Understanding and predicting the fate of micropollutants in WWTPs is helpful in
identifying the improvement potential for current treatment configurations. To date,
enormous efforts by many researchers have been put into developing accurate and succinct
models for micropollutants prediction. Precise models for micropollutant fate are not easy to
establish. Modellers should take into account numerous aspects, including possible removal
pathways and factors that affect the removal. Pomiès et al. (2013) reviewed different models
from the perspective of removal pathways. Sorption and volatilisation can be characterized
by partition coefficient Kd and Henry’s law constant, both of which can be determined
experimentally. Biodegradation modelling is a more complicated process due to the
involvement of microorganisms. Two issues have been addressed for the biodegradation of
micropollutants. First issue is the lack of conformity in determining biodegradation sites
(only in aqueous phase, only in solid phase or in both phases). The other is the incorporation
of parent compounds and by-products as well as co-metabolism in the models.
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The discharge of micropollutants can contribute to water pollution due to their
potentially ecotoxicological impacts on aquatic organisms. Furthermore, human exposure to
micropollutants is also harmful and can occur via various routes. According to Figure 1,
micropollutants can return to humans via drinking water. Other pathways back to humans
include food chain and wastewater reuse for household purposes. Given their adverse effects,
effective monitoring strategies and risk assessment should be considered as important
components for micropollutants control. Nevertheless, monitoring programmes for
micropollutants are far from universal and have only been carried out in sizable rivers, such
as Rhine (Sacher et al., 2008) and Han River (Choi et al., 2008a), as those programs are time
consuming and costly (Alder et al., 2010). Therefore, the establishment of estimation tools
for the concentrations and mass flows of micropollutants in surface waters is of vital
importance. Generally, the estimation should be based on the various sources,
use/consumption of compounds and their fate in WWTPs as well as receiving waters.
Coetsier et al. (2009) indicated predicted environmental concentrations (PECs) offers the
possibility to predict pharmaceutical occurrence in surface water. Although the PEC values
seemed to be able to properly estimate WWTP wastewater effluents, they are subjected to
uncertainties because the differences between predicted and measured values can become
significant when applied to local areas with consumption levels being considerably different
from assumed average levels.
After discharged into surface waters, micropollutants experience various processes,
including dilution and attenuation (biodgradation, sorption, volatilization and photolysis). A
comprehensive understanding and modelling of micropollutants fate in surface waters is
essential for effectively predicting micropollutants’ impacts on the receiving environment.
Although integrated urban water system (IUWS) modelling is usually used as a tool for
evaluating the quality of the surface water receiving the municipal WWTP discharge
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combining sewer overflows and stormwater drainage systems, many micropollutants tend to
distribute to more than one environmental compartment (air, water, sediment, soil,
groundwater, etc.). Hence, a multimedia fate and transport model (MFTM) was proposed by
Keyser et al. (2010) to meaningfully characterize the attenuation and distribution of
micropollutants.

6. Conclusion
Enormous research effort has been directed toward the assessment of occurrence of
micropollutants in the aquatic environment. In particular cases, the occurrence levels of some
micropollutants in surface waters were much higher than their PNECs, which revealed an
environmental concern. WWTP effluent has been considered as the primary source of many
micropollutants in aquatic systems. Given their diverse properties (e.g., hydrophobicity and
biodegradability) and low concentrations, micropollutant removal in current WWTPs is
commonly incomplete and variable, ranging from 18.8% to 91.1% for some frequently
reported compounds. Hence, optimization of wastewater treatment, in order to create an
absolute barrier to micropollutants emission, remains a task of high priority. Biological
treatment is commonly unable to remove polar persistent micropollutants. However, its
efficacy can be improved under favourable conditions (e.g., extended SRT and HRT, warm
temperature, and fine tuning redox conditions). Although advanced treatment technologies,
such as adsorption processes, AOPs and membrane processes, have been demonstrated to be
promising alternatives for micropollutant removal, there are two issues associated with the
applications of advanced treatments: high operation costs and formation of byproducts and
concentrated residues. Moreover, to effectively predict the impact of micropollutants on the
receiving environment, a comprehensive understanding and modelling of micropollutants fate
is needed.
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Micropollutants occur in the aquatic environment all over the world.
There is a large variation in micropollutant removal (12.5 to 100%) in WWTPs.
Micropollutant removal is dependent on compound- and process- specific factors.
Advanced treatment technologies achieve better micropollutants removal.
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Table 1
Sources of micropollutants in the aquatic environment
Category
Important subclasses
Pharmaceuticals

NSAIDsa, lipid regulator,
anticonvulsants, antibiotics, βblockers and stimulants

Major sources
Distinct
Nonexclusive
 Domestic wastewater (from excretion)
 Hospital effluents
 Run-off from CAFOsb and aquaculture

Personal care
products

Fragrances, disinfectants, UV filters,
and insect repellents

 Domestic wastewater (from bathing,
shaving, spraying, swimming and etc.)

Steroid
hormones

Estrogens

 Domestic wastewater (from excretion)
 Run-off from CAFOs and aquaculture

Surfactants

Non-ionic surfactants

 Domestic wastewater (from bathing,
laundry, dishwashing and etc.)
 Industrial wastewater (from industrial
cleaning discharges)

Industrial
chemicals

Plasticizers, fire retardants

 Domestic wastewater (by leaching out
of the material)

 Domestic wastewater (from improper
cleaning, run-off from gardens, lawns
and roadways and etc.)
 Agricultural runoff
a
b
NSAIDs: non-steroidal anti-inflammatory drugs; CAFOs: concentrated animal feeding operations.
Pesticides

Organochlorine insecticides,
organophosphorus insecticides,
herbicides and fungicides

Sources that are not exclusive to
individual categories include:
 Industrial wastewater (from
product manufacturing discharges)
 Landfill leachate (from improper
disposal of used, defective or
expired items)

Table 2

The concentration and removal of micropollutants in WWPTs of different countries
Sampling sites

Influent (µg/L)

Effluent (µg/L)

Removal (%)c

Referencesd

Acetaminophen

Spain, Korea, WBa

1.57-56.94

0-0.03

98.7-100

2, 5, 8, 24, 25e

Diclofenac

EU-widea, Greece, Korea,
Sweden, Switzerland, UK,
WB

<0.001-4.2

<0.001-0.69

-105-81.4

2, 8, 11, 14f, 20,
21, 24, 25, 27, 28

Ibuprofen

China, EU-widea, Greece,
Korea, Sweden, UK, US, WB

<0.004-603

NDc-55

72-100

2, 8, 11, 14, 19,
21, 24, 25, 26, 28

Ketoprofen

China, EU-widea, Korea,
Spain, UK, WB

<0.004-8.56

<0.003-3.92

11.2-100

2, 8, 11, 14, 19,
25, 27

Mefenamic acid

EU-wide, Korea, Spain, UK

<0.017-1.27

<0.005-0.39

-387.5-70.2

2, 8, 11, 24

Naproxen

Greece, Korea, Spain,
Sweden, UK, WB

<0.002-52.90

<0.002-5.09

43-95.7

2, 8, 11, 19, 21,
24, 25, 28

Salicylic acid

Greece, Spain, UK

0.576-63.7

ND-0.50

92.8-100

8, 11, 21

Carbamazepine

China, EU-wide , Greece,
Korea, Spain, UK, WB

<0.04-3.78

<0.005-4.60

-114.2-62.3

2, 5, 11, 14, 19,
24, 25, 27

Bezafibrate

EU-wide, Spain, Korea, UK,
WB

0.05-1.39

0.03-0.67

9.1-70.5

2, 8, 11, 14, 24,
25

Clofibric acid

China, EU-wide, Greece, ,
Korea, Spain, Sweden, UK,
WB

0-0.74

0-0.33

9.9-93.6

2, 11, 14, 21, 24,
25, 28

Categories
Selected compounds
Pharmaceutical
Analgesic and
antiinflammatory

Anticonvulsant

Lipid regulator

Gemfibrozil

EU-wide, Greece, Korea,
Spain, WB

0.10-17.06

<0.0025-5.24

-133.3-92.3

2, 8, 14, 21, 24,
25

Erythromycin

China, Spain, UK, WB

0.14-10.03

0.02-2.84

-100-82.5

8, 11, 24, 25, 27

Sulfamethoxazole

EU-wide, France, Korea,
Spain, Sweden, Switzerland,
UK, WB

<0.003-0.98

<0.003-1.15

4-91.7

2, 5, 8, 11, 14, 15,
20, 24, 25

Trimethoprim

China, EU-wide, Korea,
Spain, UK

0.06-6.80

<0.01-3.05

-80->88.1

2, 5, 8, 11, 14, 24,
25, 27

Atenolol

Korea, Spain, Switzerland,
UK,WB

0.1-33.106

0.13-7.60

-33.3-83.0

1, 2, 11, 24, 25

Metoprolol

China, Korea, Spain,
Switzerland, UK

0.002-1.52

0.003-0.25

3-83.5

1, 2, 8, 11, 24

Caffeine

Spain, UK, Korea, China, EUwide, Greek

0.22-209

0-43.50

44-99.8

2, 5, 14,19, 21,
24, 26, 27

Galaxolide

Spain, WB

0.03-24.97

<0.06-2.77

87.8

24, 25

Tonalide

Spain, WB

<0.05 –1.93

<0.05-0.32

84.7

24, 25

Triclosan

Spain, UK, US, Greece,
Korea , France, EU-wide

0.03-23.90

0.01-6.88

60.9-99

2, 13, 14, 15, 17,
21, 23, 24, 26

DEETa

China, EU-wide

2.56-3.19

0.61-15.80

65.6-79.5

14, 25

Antibiotic

β-blocker

Nervous stimulant

PCPa
Musk fragrance

Disinfectant

Insect repellant
UV-filter

Benzophenone-3

Korea, Spain

<0.079-0.904

<0.79-0121

78.2

2, 24

Estrone

China, France, Germany,
Italy, Korea, Sweden, US
China, France, Germany,
Italy, Korea, Sweden, US
China, France, Germany,
Italy, Sweden, US
China, Korea

0.01-0.17

<0.001-0.08

74.8-87.1

2, 9, 16, 28

0.002-0.05

<0.001-0.007

47-92.6

2, 9, 16, 28

0.001-0.003

<0.001-0.002

43.8

9, 16, 28

0.125 -0.80

0-0

100

2, 16

China, France, Germany,
Greece, Italy, Spain, US, WB
China, France, Germany,
Italy, Spain, UK, US

<0.03-101.6

<0.03-7.8

21.7-91.4

<0.2-8.7

0.004-1.3

80-99.6

4, 9, 15, 16, 17,
23, 25
4, 9, 11, 15, 16,
17, 25

<0.013-2.14

<0.03-1.10

60-95.1

DBPa
DEHPa
DMPa

China, France, Greece, US,
WB
Austria, China
Austria, China, US
Austria, China

ND-11.81
0.003-70.0
ND-6.49

ND-4.13
0.0001-54.0
ND-1.52

73.6-75.5
22.9-97
84.8-93.5

11, 15, 16, 17, 23,
25, 26
6, 7
6, 7, 26
6, 7

TCEPa
TCPPa

EU-wide, Germany
EU-wide, Germany

0.06-0.5
0.18-4

0.06-2.4
0.1-21

-105.6- -20.7
-26.2- -50.0

14, 18
14, 18

Atrazine

EU-wide, France, Spain,
Switzerland, WB
EU-wide, France, Spain,
Switzerland

0.02-28

0.004-0.73

<0-50

0.03-1.96

0.002-2.53

19-61.5

3, 12, 14, 15, 20,
25
3, 12, 14, 15, 20,
24

Steroid hormone

Estradiol
17α-Ethynylestradiol
Estriol
Surfactants
Nonylphenol
Octylphenol

Industrial chemicals
Plasticizers
Bisphenol A

Fire retardant

Pesticide
Herbicide

Diuron
Insectcide

Diazinon

EU-wide, Spain

0.684 (max)

0.0007-4.16

-111.3

3, 12, 14

Clotrimazole

EU-wide, Greece

0.012-0.08

ND-0.005

>80

10, 14, 22

Tebuconazole

Greece, Spain

ND-1.89

0.0005-0.69

19-57

3, 10, 22

Fungicide

a

WB: Western Balkan Region (including Bosnia and Herzegovina, Croatia and Serbia);
ND: not detected;
c
When the removal efficiency was not presented in a study, it was calculated using the following equation, removal efficiency (%) = (Cinf Ceff)/Cinf×100 (Cinf is the influent concentration of a compound and Ceff is the effluent concentration of a compound);
d
1. Alder et al., 2010; 2. Behera et al., 2011; 3. Campo et al., 2013; 4. Céspedes et al., 2008; 5.Choi et al., 2008a; 6. Clara et al; 2010; 7. Gao et
al., 2013; 8. Gracia-Lor et al., 2012; 9. Janex-Habibi et al., 2009; 10. Kahle et al., 2008; 11. Kasprzyk-Hordern et al., 2009; 12. KöckSchulmeyer et al., 2013; 13. Kumar et al., 2010; 14. Loos et al., 2013; 15. Martin et al., 2010; 16. Nie et al., 2012; 17. Pothitou and Voutsa, 2008;
18. Reemtsma et al., 2008; 19. Santos et al., 2009; 20. Singer et al., 2010; 21. Stamatis and Konstantinou, 2013; 22. Stamatis et al., 2010; 23.
Stasinakis et al., 2008; 24. Rosal et al., 2010; 25. Terzić et al., 2008; 26. Yu and Chu, 2009; 27. Zhou et al., 2010; 28. Zorita et al., 2009;
e
Only influent concentrations were provided in the study;
f
Only effluent concentrations were provided in the study.
b

Table 3
Human excretion rates of some common pharmaceutical compounds in the aquatic
environment (adapted from Alder, Hirsch et al., 1999; Huschek et al., 2004; Jjemba, 2006;
Ternes, 1998; and the range was selected according to Jjemba, 2006)
Excretion rate
Pharmaceutical
Low (≤5%)

Aspirin (acetylsalicylic acid), carbamazepine, gemfibrozil,
ibuprofen

Moderately low (6-39%)

Diclofenac, metroprolol, primidone, sulfamethoxazole

Relatively high (40-69%)

Bezafibrate, norfloxacin, trimethoprim,

High (≥ 70%)

Amoxicillin, ciprofloxacin, tetracycline

Table 4
Occurrence of common micropollutants in surface water from different regions
Compound
Ibuprofen
Naproxen
Ketoprofen
Diclofenac
Mefenamic acid
Carbamazepine
Gemfibrozil
Atenolol
Sulfamethoxazole
Trimethoprim
Triclosan
Galaxolide
Tonalide
Estrone
Estradiol
Ethinylestradiol
Estriol
Caffeine
Nonylphenol
Bisphenol A
TCEP
TCPP
Atrazine
Diazinon
Diuron

Canadaa,1
0.98 (79)
1 (87)
3 (749)
0.2 (284)
0.4 (25)
2.1 (87)
-

China2
ND-1417
ND-328
35-1023
ND-65
ND-2
ND-1
ND-1
36-33231
6-881
-

Costa Ricaa,3
5 (36788)
7 (9808)
14 (266)
1 (82)
41 (17036)
11 (56)
11 (263)
24 (1121446)
-

France4
ND-8
ND-6.4
ND-22.0
ND-35.0
ND-31.6
ND-34.0
ND-5.1
-

Concentration (ng/L)
Germany5,6 Greece7
1-67
3-322
0.4-39.5
0.8-1043
102-1194
124-220
3-39
35-1814
5-273
558-2704
192-215
55-162
<3-184
<4-379
-

Korea8
<15-414
<30-326
<4-595
<100-690
NDc
3.6-69.1
1.1-10.1
ND-1.9
115-336
7.5-334
-

Spainb,9
11 (39)
10(216)
72(408)

Taiwan10
5-280
10-190
1.9-3.5
0.3-60
1-2.1
1-1813
-

UK11
0.3-100
0.3-149
0.5-14
0.5-261
0.3-169
0.5-684
1-560
0.5-4
7-122
5-95
6-68
-

US12
ND-77
ND-9.6
ND-38
ND-9.1
ND-9.8
ND-225
-

PNECb
5000
37000
15.6×106
10000
25000
100000
10×106
20000
1000
18
0.02
149
10×105
330
1000
2000
1800

a. The data presented here represent median concentration with maximum concentration in the brackets;
b. PNEC: Predicted no effect concentration (Data derived from Fromme et al., 2002, Köck-Schulmeyer et al., 2013; Lin et al., 2008 and Loos et al., 2007);
1. Kleywegt et al., 2011; 2. Peng et al., 2008; 3. Spongberg et al., 2011; 4. Vulliet et al., 2011; 5. Regnery and Püttmann, 2010; 6. Reinstorf et al., 2008; 7. Stasinakis
et al., 2012; 8. Kim et al., 2009c; 9. Köck-Schulmeyer et al., 2013; 10. Lin et al., 2011; 11. Kasprzyk-Hordern et al., 2009; 12. Wang et al., 2011.

Table 5
Occurrence of selected micropollutants in groundwater from different regions
Compound
Ibuprofen
Naproxen
Ketoprofen
Diclofenac
Carbamazepine
Gemfibrozil
Bezafibrate
Atenolol
Sulfamethoxazole
Trimethoprim
Caffeine
Triclosan
Nonylphenol
Bisphenol A
Estrone
Estradiol
Ethinylestradiol
Estriol
TCEP
TCPP
Atrazine
Diazinon
Diuron

Europea,1
3 (395)
26 (2886)
0 (24)
12 (390)
2 (38)
13 (189)
0 (9)
83 (3850)
79 (2299)
0 (4)
-

Franceb,2
0
1.2
2.8
9.7
10.4
0
5.5
3.0
1.4
0.7
0.4
1.2
-

Germanyc,3,4,5
3050
<50, 2325
112
4-51
14-355
-

Concentrations (ng/L)
Spaind,6,7
185 (0-185)
204 (145-263)
256 (35-477)
165.3 (12-574)
60.8 (18-106)
47.57 (2-117)
63.56 (4-505)
39.8 (2-118)
36 (756)
5.3 (30.8)
8.8 (178)

USb,c,8,9,10
ND, 3110
40 (420)
1110, 160 (170)
130, 170 (290)
53
2550
79
147
230
1661
-

PNECe
5000
37000
15.6× 106
10000
25000
100000
10 × 106
20000
1000
10 × 105
330
1000
18
0.02
149
2000
1800

a. average concentration with maximum concentration in the brackets;
b. average concentration;
c. maximum concentration;
d. average concentration with minimum and maximum concentrations in the brackets.
e. PNEC: Predicted no effect concentration (Data derived from Fromme et al., 2002, Loos et al., 2007 and Lin et al., 2008).
1. Loos et al., 2010; 2. Vulliet and Cren-Olivé, 2011; 3. Maeng et al., 2010; 4. Müller et al., 2012; 5. Stepien et al., 2013; 6. Postigo et al., 2010;
7. Teijon et al., 2010; 8. Barnes et al., 2008; 9. Fram and Belitz, 2011; 10. Karnjanapiboonwong et al., 201

Table 6
Simple classification of micropollutants based on removal efficiency
Degree of removal
Compounds
Poorly removed (<40%)
carbamazepine, metoprolol, diclofenac
Moderately removed
(40-70%)
Highly removed (>70%)

trimethoprim, ketoprofen, clofibric acid, sulfamethoxzole,
atenolol, nonylphenol,
estrone, bisphenol A, triclosan, naproxen, gemfibrozil,
caffeine, ibuprofen

Table 7
Removals of some micropollutants during coagulation-flocculation processes
Coagulant

Dosage with pH value
presented in the
parentheses

Compound

Removal
(%)

References

FeCl3/Al2(SO4)3

25, 50 ppm (7)

Ibuprofen

12.0 ± 4.8

Diclofenac

21.6 ± 19.4

Suárez et al.,
2009)

Naproxen

31.8 ± 10.2

Carbamazepine

6.3 ± 15.9

Sulfamethoxazole

6.0 ± 9.5

Tonalide

83.4 ± 14.3

Galaxolide

79.2 ± 9.9

Bisphenol A

20

DEHP*

70

Nonylphenol

90

200 mg/L (7)

Aldrin

46

100 mg/L (7)

Bentazon

15

Not mentioned

Ibuprofen

4

Ketoprofen

4

Carbamazepine

2

Tonalide

24

Galaxolide

16

Celestolide

50

Triclosan

24

DMP

19

Octylphenol

50

FeCl3

Al2(SO4)3
Not mentioned

100, 200 mg/L (4, 7, 9)

Asakura and
Matsuto, 2009

Thuy et al.,
2008
Matamoros and
Salvadó, 2013

Table 8
Removals of some micropollutants during adsorption process
Adsorbent Dosage (mg/L)
PAC
8, 23, 43

GAC

Full scale

29 g/70.6 mL bed
volume

Full scale,
empty bed contact
time :15 min

Compound

Removal (%)

Diclofenac

96, 98, 99

Carbamazepine

98, 99, 100

Propranolol

>91, >94, >94

Sulfamethoxazole

2, 33, 62

Diclofenac

>98

Carbamazepine

23

Propranolol

17

Estrone

64

17β-estradiol

>43

17α-ethinylestradiol

>43

Galaxolide

79

Tonalide

67

Bisphenol A

66

Nonylphenol

84

Triclosan

95

Diclofenac

~100

Trimethoprim

90

Carbamazepine

75

Caffeine

45

Primidone

30

DEET

15

References
Kovalova et al.,
2013

Grover et al., 2011

Hernández-Leal et
al., 2011

Yang et al., 2011

Table 9
Removals of some micropollutants during ozonation and AOPs
Treatment

Compound

Removal (%)

O3 (5 mg/L): 15 min
(Sui et al., 2010)

Carbamazepine

>90

Diclofenac

>90

Metoprolol

80-90

Bezafibrate

0-50

Trimethoprim

>90

DEET

50-80

Tonalide

79

Galaxolide

>87

Nonylphenol

>79

Ibuprofen

83

Diclofenac

>99

Carbamazepine

>99

Sulfamethoxazole

98

Triclosan

>99

Bisphenol A

>78

Estradiol

>83

Estrone

>98

Atrazine

69

Ibuprofen

34

Diclofenac

100

Carbamazepine

23

Sulfamethoxazole

51

Atrazine

69

Ibuprofen

100 (10 min), 100 (30 min)

Diclofenac

100 (10 min), 100 (30 min)

Carbamazepine

75 (10 min), 100 (30 min)

Sulfamethoxazole

98 (10 min), 100 (30 min)

Atrazine

100 (10 min), 100 (30 min)

O3 (15 mg/L)
(Hernández-Leal et al., 2011)

O3 (5 mg/L)+H2O2 (3.5 mg/L)
(Gerrity et al., 2011)

UV254: 10 min
(De la Cruz et al., 2012)

UV254 + H2O2 (50 mg/L):
10min, 30 min
(De la Cruz et al., 2012)

Table 10
Removals of some micropollutants during membrane processes
Membrane
UF

Water type
Synthetic water

Membrane conditions
a

PES flat-sheet, 100 kDa; TMP = 0.5 ± 0.01 bar

Compound

Removal (%)

Ref

Ibuprofen

7

Jermann et al.,
2009

a

RC4 flat-sheet; TMP = 0.5 ± 0.01 bar
PES flat-sheet, 100 kDa; TMP = 0.5 ± 0.01 bar

Minor
Estradiol

RC4 flat-sheet; TMP = 0.5 ± 0.01 bar
NF

WWTP effluent

2

Up to 25

Flat-sheet, area 3.5 m ; TMP = 0.3 or 0.7 bar

Diclofenac

60

Flat-sheet, area 3.5 m2; TMP = 0.3 or 0.7 bar

Naproxen

60

Flat-sheet, area 3.5 m2; TMP = 0.3 or 0.7 bar

Carbamazepine

Minor

Filmtec NF90; TMP = 345 kPa

RO

Up to 80

Röhricht et al.,
2009; YangaliQuintanilla et
al., 2011

91

Filmtec NF200; TMP = 483 kPa

Acetaminophen

23

Filmtec NF200; TMP = 483 kPa

EE2a

90

Filmtec NF90; TMP = 345 kPa

Atrazine

97

WWTP effluent

-

Ibuprofen

99

Secondary effluent

Filmtec TW30; TMP = 9.5–10.2 bar

Ibuprofen

>99

Filmtec TW30; TMP = 9.5–10.2 bar

Sulfonamides

>93

Filmtec TW30; TMP = 9.5–10.2 bar

Diclofenac

95

Filmtec TW30; TMP = 9.5–10.2 bar

Macrolides

>99

Filmtec TW30; TMP = 9.5–10.2 bar

Bisphenol A

>99

1. Jermann et al., 2009; 2. Röhricht et al., 2009; 3. Yangali-Quintanilla et al., 2011; 4. Sahar et al., 2011
a PES: polyethersulfone; RC: regenerated cellulose; EE2: 17α-ethynilestradiol

Sahar et al.,
2011; YangaliQuintanilla et
al., 2011

Table 11
Removals of some micropollutants during MBR processes
Water type

Membrane & experimental conditions

Compounds

Removal (%)

References

Raw wastewater

Full-scale HF (Koch Puron)*;

~100
43

Trinh et al., 2012

MA 235 m ; Pore size 0.1-0.2 μm;

Ibuprofen
Diclofenac

SRT: 10-15 d; HRT: 1 d;

Carbamazepine

24

MLSS: 7.5-8.5 g/L

Sulfamethoxazole

60

Trimethoprim

30

Estrone,

~100

Estriol

~100

BisphenolA

~100

Lab-scale Polyvinylidene fluoride HF;
MA 0.2 m2; Pore size 0.4 μm;
HRT: 1 d or 3 d;
MLSS: 2.3-4.6 g/L

Ibuprofen

~100

Diclofenac

Minor

Carbamazepine

Minor

Synthetic wastewater

Lab-scale Polyethylene hollow fibre;
MA 0.2 m2; Pore size 0.4 μm;
HRT: 8, 6 and 4 h; SRT: 350 d;
MLSS: 5.2-13.7 g/L

BisphenolA

>93.7

Chen et al., 2008

Hospital effluent

Pilot-scale Submerged PES UF flat sheet;
Area 7 m2; Pore size 38 nm;
SRT: 30-50 d;
MLSS: 2 g/L

Carbamazepine

-6

Kovalova et al., 2012

Trimethoprim

96

Sulfamethoxazole

7

Atenolol

99

#

Synthetic wastewater

2

Bo et al., 2009

Synthetic wastewater

Hospital effluent

Lab-scale submerged HF UF module;
MA 0.047 m2; Pore size 0.04 μm;
SRT:70 d; HRT: 24 h;
MLSS: 8.6-10 g/L

Full-scale 5 Kubota EK 400 flat sheet;
Q 130 m/d

*hollow fibre; #MA: membrane area.

Ibuprofen

96.7 ± 0.7

Diclofenac

17.3 ± 4.2

Carbamazepine

13.4 ± 4.3

Sulfamethoxazole

91.9 ± 0.6

17β-estradiol

>99.4

17α-ethynylestradiol

93.5 ± 1.2

Bisphenol A

90.4 ± 3.1

Nonylphenol

99.3 ± 0.2

Atrazine

4.4 ± 3.7

Ibuprofen

>80

Carbamazepine

<20

Diclofenac

<20

Tadkaew et al., 2011

Beier et al., 2011

Table 12
Removals of some micropollutants during attached growth treatment processes
System
Media and experimental conditions
Compound
a
Diclofenac
BAC filter
Media: GAC;
Media height: 80cm;
Carbamazepine
Diameter: 22.5 cm;
Sulfamethoxazole
EBCT: 18 min
Gemfibrozil
a
Media: wheel shaped plastic elements
E1
SBBGR
E2
Bisphenol A
a
a
EE2
Media: K1
ASFBBR
Volume: 1.4 L
EE2
HRT: 4.3 d, 1 d, 0.3 d
EE2
a
a
Media: BMBBC
Bisphenol A
MBBR
Volume: 2.5 L
OCa
Atrazine
Diclofenac
Media: K1
Volume: 5 L
Ibuprofen
Batch experiments for 24 hours
Naproxen
Ketoprofen
Memfenamic acid
Clofibric acid

Removal (%)
~91
~95
~90
~90
62.2
68
91.8
96 (4.3 d)
81 (1 d)
74 (0.3 d)
27b
~15
~8
>80
~100
~100
~100
>80
>60

References
Reungoat et al., 2011

Balest et al., 2008

Forrez et al., 2009

Accinelli et al., 2012

Falås et al., 2013

a. BAC: biological activated carbon; SBBGR: sequencing batch biofilter granular reactor; ASFBBR: aerated submerged fixed bed bioreactor;
MBBR: moving bed biofilm reactor. K1: A type of plastic carrier rings (model K1, AnoxKaldnes, Sweden); BMBBC: Bioplastic-based moving
bed biofilm carriers; OC: oseltamivir carboxylate;
b. In this study, only mineralization of the selected compounds was evaluated. Total removal could be higher due to other removal pathway

Table 13
Comparison of micropollutants removal effectiveness in different WWTPs
Removals (%) in different types of WWTPs
Compounds
Ibuprofen

Conventional1
71 – 99

Low-cost2
38 – 99

Advanced3

Diclofenac

5 – 81

~0 – 88

78 – >99

Ketoprofen

11 – 94

~0 – 88

83 –99

Carbamazepine

10 – 59

~0 – 51

68 – 99

Estrone

75 – 87

60 – 78

>50 – >99

Bisphenol A

60 – 95

23 – 73

>58 – >98

Nonylphenol

22 – 93

56 – 85

48 – >99

>35 – 99

1. Alder et al., 2010; Behera et al., 2011; Céspedes et al., 2008; Choi K. et al., 2008; GraciaLor et al., 2012; Janex-Habibi et al., 2009; Kasprzyk-Hordern et al., 2009; Kumar et al.,
2010; Martin et al., 2010; Nie et al., 2012; Pothitou and Voutsa, 2008; Santos et al., 2009;
Singer et al., 2010; Stasinakis et al., 2008; Yu and Chu, 2009
2. Camacho-Muñoz et al., 2012; Hijosa-Valsero et al., 2010.
3. Gracia-Lor Rosal et al., 2010; Rosal et al., 2010; Schaar et al., 2010; Sui et al; 2010; Yang
et al., 2011; Zhou et al., 2010; Zorita et al., 2009;

Table 14
Assessment of different treatment processes for micropollutants removal
Technique

Common removal efficiencya

Major factors

Disadvantage/problems

Residues

 Hydrophobicity
 Molecular size

 Ineffective MP removal
 Large amount of sludge
 Introduction of coagulant salts
in the aqueous phase

Sludge






Used material
 Relatively high financial costs
 Lower efficiency in the presence
of NOMs
 Need for regeneration
 Disposal of used carbon

P

PCP

SH

IC

Process-specific

MP-related

Coagulation

L-M

M-H

L

L-H

 Dosage
 pH
 wastewater
composition

AC

M-H

M-H

H

M-H






Ozonation and
AOPs

M-H

M-H

H

M-H

 Dosage
 pH
 interfering ions (e.g.,
Br-)
 wastewater
composition

 Compound
structure

 High energy consumption
 Formation of byproducts
 Interference of radical
scavengers

Residual
oxidants

NF

M-H

H

M-H

M-H






 Hydrophobicity
 Molecular size






Concentrate

Adsorbent properties
Dosage
Contact time
pH

Membrane properties
pH
transmemrane pressure
feed quality

Hydrophobicity
Molecular size
Structure
Functional group

High energy demand
Membrane fouling
Disposal of concentrate
Desorption of sorbed chemicals
from membrane

RO

M-H

H

H

H






Membrane properties
pH
transmemrane pressure
feed quality

 Hydrophobicity
 Molecular size

 High energy consumption
 Disposal of concentrate
 Corrosive nature of the finished
water

Concentrate

Activated sludge

L-H

M-H

M-H

L-H






SRT
HRT
Organic loading
Redox conditions

 Hydrophobicity
 Biodegradability

 Micropolluants sorbed onto
sewage sludge may increase the
environmental risk
 Disposal of sludge

Wasted sludge

MBR

L-H

M-H

H

M-H






SRT
HRT
Organic load
Redox conditions

 Hydrophobicity
 Biodegradability

Wasted sludge
 Moderately high energy
consumption
 Inconsistent removal of polar
and resistant compounds
 Membrane fouling
 Micropollutants tend to sorb less
onto the aged MBR sludge

Attached growth

L-H

M-H

M-H

M-H

 HRT
 Organic loading
 Redox conditions

 Hydrophobicity
 Biodegradability

 Long start-up time
 Difficulty in control of biofilm
thickness

a. P: pharmaceutical; PCP: personal care product; SH: steroid hormone; IC: industrial chemical; L: low; M: medium; H: high

Wasted sludge

